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Zusammenfassung 
 
Spermatogoniale Stammzellen (SSCs) sind in den Samenkanälchen des Hodens 
lokalisiert und für die Samenproduktion des Mannes verantwortlich. Obwohl viel über 
die Morphologie und Kinetik der Spermatogonien bekannt ist, so gibt es doch noch 
Lücken in der Erforschung von spezifischen zellulären, mophologischen und 
biochemischen Prozessen der SSCs. 
Methoden wie die Durchflusszytometrie (FACS), Magnetic Cell Separation (MACS), die 
Matrix-Selektion und die Selektion aufgrund morphologischer Kriterien sind einige der 
sehr hiflreichen Techniken, um SSCs aus dem Hodengewebe zu isolieren. 
Wir generierten ein einfaches, aber höchst reproduzierbares Protokoll für die Isolierung 
von SSCs. Es handelt sich um eine Selektion, die auf der Morphologie der Zellen 
basiert und mit deren Hilfe wir zwei Typen von SSC-Zellen (Typ I und Typ II) selektieren 
konnten. Wir etablierten die optimalen Wachstumsbedingungen für diese zwei 
Zelltypen, indem wir Ko-Kulturen mit verschiedenen Mitomycin-C behandelten 
Feederzellen als Langzeitkultur ausgetestet haben. Damit konnten wir erfolgreich „Typ 
I-SSCs“ auf embryonalen Fibroblasten der Maus (MEFs) und „Typ II-SSCs“ auf SNL-
Fibroblasten (generiert aus STO-Fibroblasten der Maus), aber auch auf primären 
testikulären Stromazellen der Maus (TSCs) wachsen lassen. 
Elektronenmikroskopische Analysen zeigten, dass Typ I-SSCs eine ähnliche 
Mophologie mit SSCs in-vivo, mit einem typischen Kern-/Zytoplasma-Verhältnis 
aufweisen, während Typ II-SSCs eine unterschiedliche Morphologie in Bezug auf das 
Kern-/Zytoplasma-Verhältnis besitzen und einen eher kleinen Kern aufweisen. 
Die Ergebnisse von Untersuchungen mittels Immunhistologie, FACS und Fluidigm Real 
Time PCR zeigten deutlich, dass Typ I-SSCs Keimzellmarker exprimieren, während Typ 
II-SSCs nur partiell das Keimzellmarkerprofil aufwiesen.  
Weiterhin konnte man bei Busulfan-behandelten Tieren beobachten, dass 
transplantierte GFP-positive Typ II-SSCs an der Basalmembran der Hodenkanälchen 
lokalisiert sind. Ebenfalls wurden GFP-positive Spermien im Nebenhoden gefunden.  
Zu den größten Unterschieden zwischen Typ I- und Typ II-SSCs gehört ihre Fähigkeit, 
sich wieder zu  embryonalen Stammzell- ähnliche Zellen (ES- ähnlichen  Zellen) zu 
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reprogrammieren. Dies tritt in einem kritischen Zeitfenster auf, nachdem die Typ I-SSC-
Kulturen angelegt wurden. 
Obwohl man in verschiedenen Studien ES-ähnliche Zellen aus dem Hoden generieren 
konnte, so konnte das Zeitfenster, in der sich der Übergang in pluripotente Zellen 
ereignet, bislang nicht klar definiert werden.  
In unseren Experimenten konnten wir  das spontane Auftreten von ES-ähnlichen Zellen 
aus Typ I-SSC Zellen sowohl aus neugeborenen, als auch aus erwachsenen Mäusen 
beobachten, aber nur während eines speziellen Zeitfensters (Tag 41 bis Tag 125, 
nachdem die Typ I-SSC Zellkulturen aus neugeborenen und erwachsenen Promotor-
Reporter Oct4-GFP transgenen Mäusen angelegt wurden). 
Die so erzeugten ES-ähnlichen Zellen reagierten positiv auf Pluripotenzmarker. Diese 
ließen sich in-vitro in alle drei Keimbahnen differenzieren und bildeten komplexe 
Teratome, nachdem sie in NOD/SCID Mäuse injiziert wurden und produzierten chimäre 
Mäuse.  
Obwohl der exakte Mechanismus der Entwicklung der ES-ähnlichen Zellen aus SSCs 
noch unklar  ist, bieten diese neue Beoachtungen die Möglichkeit, etwas Neues über 
den Ablauf der Umwandlung der ES ähnlichen Zellen aus Mäusehoden zu erfahren. 
Daher bieten diese zwei Zelltypen I und II ein ideales Zellsystem, um sowohl 
Pluripotenz als auch die in-vitro Differenzierung der SSCs zu Spermien zu erforschen. 
Darüber hinaus findet sich hiermit eine neue Strategie, um SSCs von neugeborenen 
und erwachsenen Mäusen anhand von morphologischer Selektion zu isolieren. 
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Abstract 
Spermatogonial stem cells (SSCs) are located on the basal membrane in seminiferous 
tubules of the testis and are responsible for sperm production during the male’s life. 
Although the morphology and kinetics of spermatogonia has been extensively 
characterized, there is still a lack of specific cellular, morphological and biochemical 
criteria for SSCs. However, Fluorescence-activated cell sorting (FACS), magnetic-
activated cell sorting (MACS), matrix selection and morphology-based selection are 
some of the useful methods for the isolation of SSCs.  
In the current study, we demonstrated that using cell sorting approaches are 
dispensable for the generation of mouse SSCs cultures. We identified a simple and 
highly reproducible protocol for the isolation of SSCs with morphology-based selection 
and successfully established two types of SSCs (Type I and Type II). Using co-culture 
systems with different mitomycin-C treated feeder layers in long-term culture, we 
established the optimal conditions for the cultivation and gene expansion of these two 
types of SSCs. We successfully expanded Type I SSCs on mouse embryonic 
fibroblasts (MEFs) and Type II SSCs on both SNL and primary testicular stroma cells 
(TSCs) feeders. Electron microscopic analysis revealed that Type I SSCs display a 
similar morphology with SSCs in-vivo high nucleus/cytoplasm ratio, while Type II SSCs 
have a different morphology small nucleus/cytoplasm ratio. Immunocytochemistry, 
FACS and Fluidigm real-time RT-PCR results showed that Type I SSCs clearly express 
germ cells markers while Type II SSCs only partially express the typical germ cell profile 
of SSCs. Following the transplantation of Type II SSCs to busulphan-treated NOD/ 
SCID mice, we observed a localization of GFP-labeled cells in the basal compartment of 
the seminiferous tubule. Furthermore, GFP labeled sperms were detected in epididymis. 
Among the most obvious molecular differences between Type I and Type II SSCs were 
their reprogramming capacity to mouse embryonic stem cells-(ES-) like cells that 
occurred only on the critical time window after initiation of Type I SSCs culture. Although 
testis-derived ES-like cells have been obtained in several studies, the time window for 
the shift to pluripotency was not clearly determined. In our experiments, we observed 
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that the spontaneous appearance of germline-derived ES-like cells from both neonate 
and adult Type I cells occurred only during a special time window (41 until 125 days) 
after initiation of  Type I cells from neonate and adult promoter-reporter Oct4-GFP 
transgenic mice. The generated ES-like cells expressed pluripotency markers, 
differentiated into all three germ lineages, formed complex teratoma after 
transplantation in SCID mice and produced chimeric mice. Although the exact 
mechanism of the development of ES-like cells from GSCs is still unclear, this new 
information could provide an ideal strategy for scheduling natural conversion 
mechanisms of ES-like cells from mouse testes. Therefore, the two different types of 
SSCs could provide an ideal cell system for studying both pluripotency and in-vitro 
differentiation of SSCs to sperm and also provide a new strategy for isolation of SSCs 
from neonatal and adult mice by morphology-based selection.  
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Chapter 1 Introduction 
 
1.1. Stem cells 
Stem cells are undifferentiated cells that have the ability for self-renewal and 
differentiation into many different cell types in the body. This potential allows them to 
differentiate into derivatives of ectodermal, mesodermal and endodermal embryonic 
germ layers. According to plasticity and developmental versatility, stem cells can be 
classified into different groups.  
Totipotent stem cells are the only type of stem cells that have the potential to develop 
into every cell type in the body. A combination of sperm cell and an egg cell form a 
fertilized egg that becomes totipotent stem cells. Totipotent stem cells can specialize 
into pluripotent stem cells in a few days after development of embryonic cells. 
Pluripotent stem cells are derived from the inner cell mass of the blastocyst and similar 
to totipotent stem cells, they can give rise to all tissue types expect extra-embryonic 
derivatives.  
Some types of stem cells have less plasticity potential and they are more differentiated 
stem cells. These types of stem cells are multipotent stem cells such as mesenchymal 
stem cells and blood stem cells that can develop into different cell types in the body. 
In stem cell classification, multipotent stem cells are in the category of adult stem cells. 
These cells exist in the adult organs and are able to proliferate and maintain their 
differentiation potential during in-vitro culture [1]. Adult stem cells can replace cells that 
have died or lost their function. They are undifferentiated cells which are present in 
differentiated tissue, for example, in mesenchymal, hematopoetic (blood), neural, 
endothelial, muscle, gastrointestinal and epidermal cells. 
A few types of stem cells in adult tissues are unipotent which means that these stem 
cells are able to differentiate into only one cell type in the body, for example, SSCs and 
ovarian stem cells that exist in the testis and the ovarian tissue.  
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1.1.1. Pluripotent stem cells 
As mentioned, pluripotent stem cells are undifferentiated cells which have potential for 
self-renewal and differentiation into many cell types in the body. This ability of 
pluripotent stem cells allows them to be used in regenerative medicine for cell therapy.  
Pluripotent stem cells can proliferate and maintain pluripotency during in-vitro culture 
[1]. 
Several extrinsic growth factors with activation of associated signaling pathways 
determine the fate of pluripotent stem cells. Proliferation of pluripotent cells occurs in 
the presence of feeder, growth factors and high concentration of FBS. In the mESCs 
culture, growth factors such as BMP4 (bone morphogenetic protein 4) and LIF 
(leukemia inhibitory factor) can replace serum and the feeder cell layer [2]. Observation 
indicated the LIF and BMP4 signaling pathways promote activation of STAT3 and 
SMAD1 proteins respectively [2, 3]. In the hESCs culture, it has been demonstrated that 
BMP4 promotes differentiation into trophoblast cells, while Activin/Nodal and FGF 
signaling pathways maintain self-renewal and pluripotency of the human cells [4, 5]. In 
addition to these signaling pathways, activation or inhibition of STAT3, MAP kinase 
(MEK) and glycogen synthase kinase 3 (GSK3) are important to sustain the 
pluripotency state [6, 7].   
 
1.2. SSCs as adult stem cells 
 
1.2.1. Development of germ cells and SSCs  
Primordial germ cells (PGCs) are specified from pluripotent proximal epiblast cells 
during fetal development. In the epiblast stage of mouse embryo at about 6 days post 
coitum (dpc), extraembryonic ectoderm (EXE) and visceral endoderm tissues secrete 
BMP4, BMP8b and BMP2 signals that influence pluripotent proximal epiblast cells. In 
response to these extraembryonic signals, some of the cells express fragilis/Ifitm3 and 
acquire PGC competence. Fragilis encodes E-cadherin protein that is involved in 
homotypic cell adhesion and cell-cell interaction. At embryonic day 6.25 (E6.25), among 
fragilis/Ifitm3 positive cells which are in contact with EXE, about 6 cells express 
Blimp1/Prdm1 and acquire PGC specification. The number of specified cells increases 
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to 16 in stage E6.5 [8]. In these cells, Blimp1 proteins repress activation of the somatic 
program allowing the specification of germ cell characters [8, 9]. The specified PGCs 
start to express some genes such as tissue non-specific alkaline phosphatase (Tnap) 
[10, 11], stage specific embryonic antigen 1 (SSEA1) [12], Stella [13], Sox-2 [8, 14], 
Nanog [15] and Prdm14 [14]. PGCs and non-specified competent cells also express 
mesodermal genes such as Hoxb1, T, Fgf8, and Snail [16]. The development of PGCs 
continues during their migration from E7.5 to E11.5.  At E9.0, PGCs migrate through the 
primitive streak and merge into the hindgut while freely moving around the cells of the 
hindgut epithelium. Between E7.5 and E9.5, PGCs undergo an extensive epigenetic 
reprogramming that mainly consists of a transition from genome-wide suppressive 
H3K9me2 histone mark to a more permissive mark, the H3K27me3 [17]. This process is 
apparently coordinated by a protein-binding protein, Mad2l2 [18]. Next, PGCs appear 
from the dorsal side of the hindgut and migrate towards the developing genital ridges at 
E9.5. At E10.5, they evolve to form clusters of cells. Finally, at E11.5, most PGCs 
emerge in the form of a colony in the genital ridge, where they undergo a second round 
of epigenetic reprogramming to acquire the potential for pluripotency [19-21]. 
During the move to the genital ridge, some growth factors control PGCs. These include 
TGF, bFGF, EGF, Interleukins, steel factor, as well as some of the ECM proteins like E-
cadherin and b1 integrin.    
At E12.5, in both males and females, mitotic cell division of PGCs discontinues and 
instead the process of sexual differentiation starts to appear. In females, germ cells 
(GCs) become oocytes in the ovary by entering into the prophase of meiosis I at E13.5, 
and at E15.5, most of the ovarian GCs transit to the meiotic prophase I [22]. Oocytes 
pause in E17.5, in the diploten stage of meiosis phase, and resume after birth while 
surrounded by a single layer of somatic cells and forming a primordial follicle [23]. 
Most often, male germ cells do not show a tendency to enter the meiosis phase until 
after birth. Approaching 2.5 dpc, somatic cells in the testis produce meiosis-inhibiting 
factor that blocks the entry of germ cells into meiosis and their development in the 
spermatogenic pathway [24]. At the 13.5 dpc, PGCs turn into gonocytes, which become 
enclosed in testicular cords formed by Sertoli precursor cells and peritubular myoid cells 
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[25, 26]. Gonocytes can be classified into I-gonocyte or M-prospermatogonia (mitotic 
prospermatogonia), which are located in the center of the testicular cords; however, 
their morphology is similar to oogonia in females [27, 28]. M-prospermatogonia continue 
proliferating until 16.5 dpc of mouse development and give rise to II-gonocytes or T1-
prospermatogonia (primary transitional prospermatogonia, as these cells represent the 
first state of transition between the M-prospermatogonia and the A-spermatogonia) and 
enter G0 mitotic arrest [26].  
During the first week after birth, T1-prospermatogonia migrate to the seminiferous 
tubules that give rise to T2 prospermatogonia (secondary transitional 
prospermatogonia, which represent the second state of transition to the A-
spermatogonia) and colonize the basement membrane, and can enter into the 
spermatogenesis pathway during post pubertal life [29, 30]. 
 
1.2.2. The SSCs Niche  
The testes of mammals are especially responsible for producing both spermatozoa and 
secretion of male hormones. The reproductive system, the testes in the male mammals, 
are placed within the scrotum covered by connective tissue called tunica albuginea 
(capsule). Testes are divided into testicular lobules, which constitute 1-4 seminiferous 
tubules that are separated by septum. Seminiferous tubules are connected to the Rete 
testis. The seminiferous tubules release their spermatozoa into Rete testis, which are 
then conducted to the 7-15 efferent ducts. Each testis is covered by the epididymis and 
adipose tissue (the epididymal fat body). The spermatozoa migrate to the epididymis for 
maturation.  
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Figure 1.1: Spermatogenesis in the mammalian testes. Figure adapted from reference [31].  
 
SSCs are the adult stem cells of the testis that are involved in spermatogenesis, with a 
diameter approximately about 14 µm in size, that form after birth and keep their activity 
throughout a male’s life. The number of undifferentiated SSCs are seldom observable in 
the testis, confirmed by the fact that rate of the SSCs in the adult mouse testis is only 1 
in 3000 cells [32]. SSCs reside directly in the germline epithelium above the basal 
membrane of the seminiferous tubules surrounded by Sertoli cells. In the periphery of 
the seminiferous epithelium, patches of interstitial tissue containing blood vessels, 
Leydig cells and macrophages are located (Figure1.1 A and B). These types of somatic 
cells secrete some factors that control self-renewal and differentiation of SSCs [33].  
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1.2.3. Division and differentiation  
SSCs have the potential for division and differentiation in a cascade to spermatocytes, 
spermatids and sperm in order to transmit genetic information to the next generation. 
Differentiation of undifferentiated SSCs to spermatocyte cells is associated with a 
change in the gene expression profile and the cell morphology that is obvious in the 
sperm cells. 
During the division of undifferentiated spermatogonia in rodents, daughter cells derived 
from As (A-single) spermatogonia can either move away from each other to guide to 
stem cell renewal or can stay together as a pair of so-called Apr spermatogonia. Finally, 
this process produces aligned spermatogonia (Aal) cells that are connected by 
intercellular cytoplasmic bridges. Undifferentiated SSCs like As, Apr and Aal proliferate 
with two symmetric and asymmetric divisions models (Figure1.1 C) until epithelial stage 
VII-VIII, in which most of the Aal spermatogonia differentiate to A1 spermatogonia 
without any divisions. During asymmetric division, undifferentiated As spermatogonia 
can convert to two As or two progenitor Apa spermatogonia cells. Alternatively, during 
asymmetric division, As spermatogonia can give rise to two As or At (transient) SSCs 
[31,34, 35].  The Aal spermatogonia, can give rise to several generations of 
spermatogonia including A1–A4, intermediate, and type B cells [36]. There are usually 
six generations of differentiated SSCs in mammalians that produce spermatocytes after 
synchronous division [37, 38]. Cell cycle property and proliferation patterns are altered 
during differentiation of Aal to differentiated A1 spermatogonia [39]. Type B differentiated 
cells produce spermatocytes, spermatids, and mature sperm.  
In primates, the undifferentiated spermatogonial population appears in two types: Adark 
and Apale. It has been proposed that Adark cells are the reserve spermatogonia and they 
have very slow cyclin, which are unable to contribute to spermatogenesis pathways and 
can only convert to Apale cells. In contrast, Apale cells can divide mitotically and give rise 
to Type B and primary spermatocytes [40, 41]. 
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1.2.4. Isolation of SSCs  
Although SSCs do not show any highly specific markers for their enrichment, in general 
these cells have been isolated by different approaches: 
First, by using extracellular matrixes such as laminin and collagen [42, 43]. SSCs 
express the surface markers a6 and b1 Integrins which bind to laminin [44]. On the 
other hand, due to a higher affinity of somatic cells for collagen, collagen-binding 
enrichment of testis somatic cells (Sertoli, Leydig and fibroblast cells) is another 
practical method for separation of somatic cells from SSCs in testicular cells [42].  
 
Markers References Markers References Markers References 
A6 
integrin(CD49)
+
 
[44] MCAM
+
 [45] Laminin
+
 [44, 46] 
B1 
integrin(CD29)
 +
 
[44] EPCAM
+
 [47] Collagen
-
 [42] 
C-Kit
-
 [48] GFRa1
+
 [49, 50] Gelatin
+
 [51] 
CD24
+
 [48] GPR125
+
 [52] MHC1
-
 [48] 
CD51
-
 [53] CD45
-
 [54] Thy-1
+
 [48] 
CDH1
+
 [55] CD9
+
 [56] Stra8
+
 [57] 
Rhodamine 123 [58] 
 
Table 1.1: MACS selection of SSCs against different markers 
 
Another strategy for the enrichment of SSCs is by using fluorescence-activated cell 
sorting (FACS) or magnetic-activated cell sorting (MACS) against a number of different 
surface markers of α6 (CD49) and β1 (CD29) Integrins [44, 59], CD9 [56], E-Cadherin 
[55, 60], THY-1(CD90) [61], GFRa1 [50, 62] that are expressed on the cell surface of 
SSCs (Table 1.1). However, one of disadvantage in this method is the lack of specific 
molecular surface markers for isolation of SSCs. 
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The third approach is a morphology-based selection of SSCs after cultivation of total 
testicular cells on gelatin-coated dishes [49, 51, 63-65]. This method can be more 
valuable in comparison to other methods due to typical cellular morphology of SSCs (as 
mentioned above, they have aligned or chain morphology) with somatic cells (cells 
spread strongly through culture plate). However, combinations of these methods are 
also used for enrichment of SSCs [42]. In our recent experiment, we isolated human 
SSCs using CD49f magnetic activated cell sorting and collagen−/laminin+ matrix 
binding selection from primary testis cultures which were obtained from adult men testis 
[66]. Although several methods for the enrichment of SSCs exist, there is still a 
disadvantage for the specific identification of SSCs.  
Transplantation of SSCs to the seminiferous tubule of infertile recipients is the strongest 
technique for identification of SSCs, because only SSCs are capable of regenerating 
spermatogenesis after transplantation [67, 68].  
In the recent years, researchers have been attempting to isolate similar cells with SSC 
potential from other sources of stem cell types [69, 70]. 
It has been demonstrated that MSCs have the potential to improve germinal repairing in 
testicular seminiferous tubules and also recovery of fertility in rat azoospermia models 
[71, 72]. Similarly, Yazawa et al showed that MSCs might also have the potential to 
differentiate into Leydig or adrenocortical cells [73]. In addition, mESCs have been 
shown to give rise to PGCs, sertoli cells and male gametes [69, 74].    
 
1.2.5. Culture of SSCs 
The underlying molecular mechanisms regulating proliferation, self-renewal, apoptosis 
and differentiation of SSCs are not completely understood. For example, various soluble 
growth factors, different types of basal media, concentrations of FBS and different types 
of feeder cells have critical roles in the differentiation, proliferation and self-renewal of 
SSCs during in-vitro culture. For example Kubota and colleagues showed that SSCs did 
not grow on newborn (NB) testis feeder, and in 10% of FBS in the presence of either 
MEM-a or F10 medium, despite the fact that they could significantly increase on STO 
feeder and 10% of FBS in presence of MEM-a (not F10 medium) [75].  
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Under serum-free culture conditions, the number of SSCs gradually decreased after the 
first week of culture [75]. Shinohara and colleagues presented a defined medium (Stem 
Pro-34 SFM; Invitrogen, Carlsbad, CA), which is still popular for SSCs cultivation [76]. 
They derived SSCs from neonate mouse testes and showed that SSCs can be 
cultivated in the presence of GDNF, FGF2, epidermal growth factor (EGF), LIF and 1% 
serum on mitomycin C-treated mouse embryonic fibroblasts (MEFs) for long term. It 
was shown that under a feeder-free culture condition and serum, SSCs can be 
cultivated for long term, although in the absence of both factors, proliferation of cells is 
slower than in adherent culture on MEF [43, 77]. For goat SSCs, a low concentration of 
serum is beneficial for short-term culture, but the expansion of SSCs for long-term 
culture depends on an increased serum concentration in the culture media [78]. 
 
1.2.5.1. Feeder 
Although there are some reports on feeder-free culture of SSCs [43, 77], one of the 
main factors for growing SSCs are feeder layers. So far, different feeder layers were 
used for the cultivation of SSCs. MEF feeder are currently applied for most of the SSC 
cultivations [76, 79].  It has been reported that the GPR125 (an orphan adhesion-Type 
G-protein-coupled receptor) positive testis cells can be cultivated on testicular feeders 
containing CD34 positive cells [52]. It has been also been shown that the STO (SIM 
mouse embryo-derived thioguanine and ouabain-resistant fibroblasts) feeder cell line 
could be considered useful for in-vitro cultivation of SSCs [80, 81]. It has also been 
documented that STO feeder are able to maintain mouse neonate Thy-1 positive cells 
and bovine testicular germ cells under short-term cultivation conditions [75, 82]. The 
SNL cell line derived from the mouse fibroblast STO cell line expresses the neomycin 
resistance and LIF genes abundantly [83]. SNL feeder supports the derivation and 
maintenance of human induced pluripotent stem (iPS) cells [84]. However, an STO 
feeder layer could not be useful for self-renewal of rabbit germ cells while the mouse 
yolk sac-derived endothelial cell (C166) feeder layers could support proliferation of non-
rodent SSCs [85]. TM4 or SF7 somatic Sertoli cell lines reduce the in-vitro maintenance 
and stem cell number of mouse male germ line stem cells [86]. Unlike ST2 and PA6 
bone marrow stromal cell lines, the OP9 bone marrow stromal cell line has a positive 
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effecton maintenance of SSCs [86].  Extracellular nanofibrillar matrix could also support 
the maintenance of mouse neonate SSCs in short term cultivation [87].  
 
  
1.2.5.2. Growth factors 
Soluble growth factors and adhesion molecules play a crucial role for the maintenance 
of SSCs during cultivation. GDNF is an important growth factor for SSCs cultivation 
(Figure 1.2). It is a distant member of the transforming growth factor–b superfamily 
(TGF-B) that was detected for the first time in dopaminergic neurons to promote survival 
of neuronal cells during activation of cAMP-dependent signaling pathways [88, 89]. 
GDNF has a vital role in regulation of SSCs in the testis. By binding to a receptor 
complex which consists of C-Ret (transmembrane tyrosine kinase) and GFRa1 (GDNF 
family receptor alpha 1) in mammalian testis, GDNF exerts its activity [90]. This 
molecule promotes self-renewal and proliferation of SSCs during in-vitro cultivation and 
was identified as an essential molecule that inhibits differentiation of SSCs and supports 
the maintenance of the stem cell pool in-vivo [79, 91-93]. Usually, a 10 ng/ml 
concentration of GDNF is sufficient for SSCs culture, but in some experiments it has 
been observed that a 100 ng/ml concentration of this protein increased colony formation 
in the SSCs culture [86, 94]. Similarly, GDNF in combination with soluble growth factors 
GFRa1 and FGF2 significantly enhanced proliferation and long-term expansion of 
mouse SSCs in cultivation [79]. In the porcine testicular cells, bFGF decreases the 
expression level of Nanog and PLZF but it could increase the expression level of Oct-4 
and GATA4 [95]. LIF is one of the essential molecules for maintenance of pluripotency 
in ESCs [96], which enhances survival of Sertoli cells and stimulates the proliferation of 
quiescent gonocytes and SSCs cells in the mouse testis [79, 97].  Growth factors 
including FGF, EGF, LIF and steel factor do not affect individually on maintenance of 
SSCs which cultivated on the STO feeder. However, FIK-2L growth factor (used for 
cultivation of hematopoietic cells) reduces colony number of SSCs [86]. Growth factors 
LIF, GDNF, EGF, FGF, IGF and SCF do not have any significant effect on SSC activity 
individually during the first week of serum-free culture system [75]. 
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Figure 1.2: Effect of different growth factors from Sertoli cells (A) and Leydig cells (B) on SSCs. 
 
The presence of GDNF, GFRa1 and bFGF (but not LIF) increased the growth of rat 
SSCs in a short-term culture [98]. Therefore, similar to the mouse SSC culture, a 
combination of growth factors GFRa1, FGF and LIF in the presence of GDNF supports 
the proliferation of rat SSCs after 7 days of cultivation [98]. It was reported that LIF, 
SCF, IGF-1 and Noggin growth factors (an antagonist for bone morphogenetic proteins) 
have effects on proliferation of mouse SSCs in-vitro [79]. In goat SSCs, a combination 
of growth factors of EGF, FGF, LIF and GDNF maintain the undifferentiated state of 
SSCs during 2-week cultivation [99]. Activin A and bone morphogenetic protein 4 
(BMP4) molecules decrease the maintenance of mouse SSCs (Figure 1.2) [86, 100]. 
 In the rat SSCs, BMP4 increases the expression of the early differentiation marker C-
Kit and up-regulates the expression of cell adhesion molecule CDH1 [101]. Both Activin 
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A and B molecules induce rat spermatogonial proliferation in a co-culture system with 
Sertoli cells [102].  
 
1.2.6. Regulation of SSCs 
Similar to other adult stem cells, SSCs undergo both self-renewal and differentiation, 
which are controlled by extrinsic factors from the cell niche and by intrinsic gene 
expression patterns. In the stem cell compartment of the basement membrane of the 
seminiferous tubules, somatic Sertoli cells exist and surround the base membrane of 
the undifferentiated SSCs. The development of undifferentiated SSCs to sperm 
depends on the interaction of SSCs to Sertoli cells and outlying peritubular myoid cells 
[103]. Sertoli cells determine the fate of SSCs by producing different growth factors 
(Figure 1.2). Production of glial cell line-derived neurotrophic factor (GDNF) and 
fibroblast growth factor 2 (FGF2) from Sertoli cells promote self-renewal and 
proliferation of SSCs, while production of activin A and BMP4 regulates differentiation of 
SSCs (Figure 1.2).  
 
 
Figure 1.3: Regulation of SSCs. Figure adapted from references A [104], B [6]. 
 
 
FGF2 promotes self-renewal of SSCs by activation of MAP2K1 and upregulation of 
transcription factors Etv5 and Bcl6b [105]. 
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Major regulators of GDNF concentration are testosterone and the follicle-stimulating 
hormone (FSH), which are secreted by Leydig cells and the hypothalamus, respectively 
[106]. SSCs express the receptors for GDNF, c-Ret, and GFRa1 [107]. This effect is 
mediated by the Akt and Src family kinase (SFK) signaling pathways (Figure 1.3) [80, 
108]. In addition, SSCs express the transcription factors PLZF, Taf4b, Bcl6b, Etv5, and 
Lhx1 that stimulate self-renewal and maintenance of SSCs (Figure1.3). In early 
spermatogonia, the transcription activity factors Bcl6b, Etv5, and Lhx1 are controlled by 
GDNF and PLZF, which inhibit the expression of the differentiation receptor c-Kit 
(Figure 1.3) [109]. Both Activin A and BMP4 reduce the maintenance of SSCs and 
promote differentiation of these stem cells (Figure 1.2) [86]. Interstitial Leydig and 
peritubular myoid cells produce CSF1 that increase the proliferation of undifferentiated 
SSCs (Figure 1.2) [110]. 
 
1.2.6.1. Role of different markers on SSCs 
As mentioned above, spermatogenesis is regulated by endocrine, paracrine and 
autocrine growth factors which are produced by sertoli cells, germ cells, peritubular 
cells, Leydig cells and macrophages. The interactions between growth factors activated 
different proteins and signaling pathways, which can direct the fate of SSCs. In the 
below table, we listed most of the popular germ cells proteins which are active during 
germ cell development (Table 1.2).   
 
Markers Property Ref. 
Oct-4 Crucial molecule for SSCs property but not in cell survival. [111] 
VASA 
Required for proliferation and differentiation of mouse male germ cells during 
development 
[112] 
DAZL Required for the entry into meiosis in the adult rat testis [113] 
STRA8 Plays a role in the pre-meiotic phase of spermatogenesis [114] 
GFRa1 
GDNF receptor is expressed in undifferentiated SSCs and is important for the 
maintenance of SSCs. 
[115, 
116] 
C-Ret 
Ret tyrosine kinase/GFRa1 receptor complex through GDNF signaling 
activates self-renewal of  SSCs 
[117] 
C-Kit Positive in the end stage of undifferentiated SSCs and differentiated SSCs [118] 
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PLZF, BCL6B, 
ETV5, LHX1, 
TAF4B 
These transcription factors are required for self-renewal, proliferation and 
maintenance of SSCs 
[60, 
119, 
120] 
Nanog Expressed in neonate pig  testis germ cells but progressively lost with age [103] 
Sall4 
There is an antagonism between Sall4 and PLZF to induce expression of Kit. 
Sall4 is expressed in As, Apr and Aal  SSCs and has overlap with expression of 
PLZF, Nanog, Kit and GFRa1. 
[105, 
121, 
122] 
Lin28 (Tex17) Expressed in undifferentiated SSCs [123] 
Foxo1 Essential for SSC homeostasis and the initiation of spermatogenesis [124] 
PTEN,TRP53 Suppresses Nanog expression in SSCs [125] 
AKT 
Plays a role in self-renewal division of SSCs during activation of 
phosphoinositide-3 kinase (PI3K-Akt) signaling pathway 
[126] 
Klf4 
Plays a role during spermatogenesis but lack of KLF4 alone does not prevent 
complete spermatogenesis 
[126] 
UTF1 
Expressed in gonocytes but decreased during further testicular development 
to a subset of A spermatogonia. 
[127] 
N-Myc 
GDNF with activation of PI3K-Akt signaling and Src kinase up-regulate N-Myc 
expression 
[94] 
 
Table 1.2: Role of different markers during germ cells development. 
 
1.2.7. Transplantation and functionality 
Differentiation of undifferentiated SSCs takes place in the adluminal compartment of the 
seminiferous tubules of the testis. As discussed above, undifferentiated SSCs can be 
isolated and expanded during in-vitro culture. Although SSCs express some of the germ 
cell markers, they lack any specific marker for identification. Therefore, transplantation 
is an efficient opportunity to study identification and functionality of SSCs because SSCs 
in recipient testis have the ability for colonization in the testis and can restore 
spermatogenesis in infertile mouse models. This functional SSC characterization 
system was identified for first time by Brinster and his colleagues [67, 128]. This group 
showed colonization of seminiferous tubules of an infertile recipient mouse model after 
transplantation of SSCs into testes. The efficiency of colonization of adult testicular cells 
was higher than neonate testis cells (gonocytes), and donor cells had normal 
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differentiation spermatogenesis and produced mature sperm [67, 128]. In cultured 
undifferentiated SSCs, one single SSC has the potential for colonization in recipient 
testis [129]. 
The Brinster group demonstrated that ESCs generate tumor in recipient testis and could 
not replace colonization of testicular cells [67]. The efficiency of transplantation also was 
not enhanced by an increased number of Sertoli cells [67]. Infertility in recipient animal 
models can be attained by Busulfan treatment or irradiation. These factors decrease 
size of testis, deplete endogenous germ stem cells and spermatogenesis in 
seminiferous tubules of testis. Infertile mouse models can also be generated naturally 
from W/Wv mutant males. There is mutation in tyrosine kinase domain of KIT which is 
necessary for proliferation and migration of PGCs during development [130].   
Most testis transplantation research was conducted in mouse models. Because of the 
long time-duration requirement for sexual maturation and also the lack of possible 
models for primate, xenografting transplantation into mouse has provided a useful 
method for study of spermatogenesis and infertility in recent years [131-133].  
 
1.2.8. Pluripotency of mouse SSCs 
Pluripotent stem cells were achieved by several methods. One technique includes the 
generation of ES cells from the inner cell mass of an embryo at the blastocyst stage [1, 
134]. In humans, this model is associated with major ethical problems. Another 
approach for the generation of pluripotent cells is by induction of pluripotency genes 
including Oct4, Sox2, Klf4 and c-Myc into somatic cells, which give rise to a so-called 
induced pluripotent stem cells (iPSCs) [135, 136]. This technique is a simple and 
promising method for the generation of patient-specific stem cells, however, the cells 
are manipulated by extrinsic factors (including, viruses, DNA, RNA, proteins and/or 
small molecules), which might be somehow problematic in regenerative medicine. 
Furthermore, the use of oncogenes like c-Myc and Klf4 for the production of iPSCs led 
to controversy about the medical application of these cells.  
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One of the promising methods for the establishment of pluripotent stem cells is with 
SSCs [51, 52, 57, 137]. Recently, generation of ES-like cells from neonatal and adult 
SSCs has been reported by several researchers [51, 52, 57, 137, 138].  
Although SSCs are unipotent stem cells, under specific culture conditions and without 
any exogenous pluripotency genes they can convert to pluripotent embryonic ES-like 
cells that can differentiate into a number of cell lineages comprising the three embryonic 
germ layers [42, 51, 137].  
Generation of PSCs from mouse testis cells dates back to 2004 by Kanatsu Shinohara 
[137] when they generated ES-like cells in SSC culture from two-day-old pups. In these 
experiments, ES-like cells were shown to be phenotypically similar to mouse ESCs and 
have the potential for in-vitro and in-vivo differentiation into various cells types. 
Furthermore, these ES-like cells contribute to the formation of germline chimeras after 
being injected into blastocysts. These results proved the potential of pluripotency of the 
SSCs or gonocytes derived from neonatal testis but the origin of ES-like cells was not 
clear. Later on, ES-like cells were generated from GFP-marked populations of STRA8-
positive [57], GPR125-positive [139] and Oct-4-positive [51] cells in the mouse testis. 
Guan et al. demonstrated that SSCs from adult mouse testes could generate 
multipotent cells in-vitro while these cells could be differentiated in three germ layers 
during in-vitro and in-vivo condition and also formed germline chimeras after injected 
into blastocysts [57]. Conrad et al derived human ES-like cell line from enriched human 
SSCs of the adult testes. In their experiments, human ES-like cells differentiated into 
three germ layers during under in-vitro and in-vivo condition and showed molecular 
characteristics with some similarities to human ESCs [42]. 
In recent years, it has been demonstrated that chemicals can enhance generation of 
ES-like cells. In neonate mouse testicular culture, inhibition of glycogen synthase 
kinase-3 promotes derivation of pluripotent (ES)-like cells [138].  
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1.3. Aim of the study 
 
In our experiments, in a first step we intended to identify different patterns of gene 
expression for testis cells which are located in the seminiferous tubule of mouse testis 
such as undifferentiated SSCs, differentiated SSCs and Sertoli cells (in-vivo analysis). 
 
Also during in-vitro culture, with morphology-based selection, we wanted to identify 
different types of cells in the testicular cultures and after characterization we aimed to 
analyze the best conditions for expansion and long term cultivation of the different cell 
populations. 
 
Furthermore, in the main part of this study –the generation of pluripotent stem cells- we 
tried to answer the question which cell population (based on morphology selection) in 
the testicular culture could show spontaneous reprogramming to a pluripotency state. 
By several in-vitro and in-vitro characterizations we intended to compare the 
pluripotency potential of testis derived ES-like cells in comparison to mESCs and 
testicular cells. 
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Chapter 2 Materials and Methods 
 
2.1. Materials 
Consumable items include materials, enzymes, chemicals, solutions and growth factors 
for cell culture, histology, electrophysiology and EM, which are described in detail in the 
Appendix (Appendix, Tables.1-34). In addition, antibodies used for staining, primers 
used for PCR, TaqMan gene expression assays for multiplex qRT-PCR and 
concentration of components in the associated solutions and mediums are described in 
more detail in the Appendix (Appendix,Tables.1-34). 
 
2.2. Methods 
2.2.1. Digestion of testis 
All animal care was in accordance with the approval of the Institute for Anatomy and 
Cell Biology in the University of Heidelberg (Heidelberg, Germany) and the Royan 
Institutional Review Board and Institutional Ethical Committee (Tehran, Iran). Testis 
cells were isolated from C57BL/6, 129/Sv mouse strains of 6-day to 6-month old Oct4-
promoter reporter GFP transgenic mice after decapsulation and treatment by a one-step 
enzymatic digestion protocol. After removing of the tunica albuginea, dissociated 
testicular tissue was placed in a digestion solution (Appendix, Table 10) at 37°C for 8 
minutes. Digestion enzymes were stopped with 10% ES cell-qualified FBS and in 
addition, pipetted up and down to obtain a single cell suspension. After centrifugation, 
specimens were washed with DMEM/F12, filtered through a 70 μm cell strainer and 
centrifuged for 10 minutes at 1500 rpm (Figure 2.1). The supernatant was removed and 
the suspension of testicular cells was plated onto 0.2% gelatine-coated culture dishes. 
23 
 
 
Figure 2.1: The digestion process of the mouse testis was as follows: macroscopic dissection of the testis 
(A) and (B), mechanical separation of seminiferous tubules after decapsulation of tunica albuginea (C), 
exposure of separated seminiferous tubules with digestion enzymes (D), separation of tissue pieces with 
filter mesh (E), ell Testicular cell pellet obtained after centrifuge (F).   
 
2.2.2. Culture of testicular cells 
As we mentioned the suspension of digested testicular cells was plated onto 0.2% 
gelatine-coated culture dishes. Approximately 0.2-0.5 × 105 cells plated per 3.8 cm2 for 
neonate and 2 × 105 cells per 3.8 cm2 for old mouse. Cells cultured in the mouse GSC 
(mGSC) medium consisted of stemPro-34 medium, N2-supplement, D+ glucose, bovine 
serum albumin, L-glutamine, β-mercaptoethanol, penicillin/streptomycin, MEM vitamins, 
NEAA, estradiol, progesterone, EGF, FGF, GDNF, LIF, ES-FBS, ascorbic acid, pyruvic 
acid and DL-lactic acid with 37°C and 5% CO2 in air (protocol for preparation of mGSC 
medium is mentioned in the appendix, Table 11). 
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2.2.3. Generation of ES-like cells 
Neonate and adult mouse testicular cells were cultivated in GS medium. Type 1 cell 
colonies were manually picked in primary culture or after subculture of primary 
supernatants into MEF feeder layer. ES-like colonies were generated from Type I cells 
in a time window between 40-125 days after initiation of culture (Figure 2.2).  
  
 
 
 
 
 
 
 
 
 
Figure 2.2: Protocol for the generation of ES-like cells from mouse testis:  
Single cells of ES-like colonies were obtained after trypsinization under mouse ES 
medium condition consist of KO-DMEM (or DMEM high-glucose medium), FBS, MEM 
NEAA solution, L-glutamine, Pen-Strep, mercaptoethanol and LIF (Appendix, Table 12) 
under MEF feeder layer. ES-like colonies were grown in mESCs media and were 
passaged every 3-4 days. In the beginning of culture, some of Type 1 cells (especially 
in neonate mice) expressed low level of Oct4-GFP but this signal was down-regulated 
after long term culture. During cultivation of Type I cells, we found colonies (rate of 
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about 33%)  which were similar to mESCs (ES-like cells) or cultured epiblast cells that 
expressed high level of Oct4-GFP about 41-125 days after initiation of culture.  
Generated ES-like cells were subcultured in mESCs medium (Appendix, Table 12). ES-
like cells reached confluence about 4-5 days after initiation of culture. Cells were 
passaged to a new MEF feeder after washing with PBS and treatment with Trypsin-
EDTA for 3min. Trypsin-EDTA was inactivated with 15% of FBS. 
 
2.2.4. Preparation and culture of different feeders 
2.2.4.1. SNL feeders 
We commercially ordered SNL 76/7 feeder cells (CBA-316) that were established by Dr. 
Allan Bradley [83]. SNL feeder cells were grown in the present of D-MEM, FBS, MEM 
NEAA solution, L-glutamine, ß-mercaptoethanol and Pen-Strep (Appendix, Table 13) on 
T-75 tissue culture flask at 37 °C and 5% CO2. SNL cells were passaged when the 
cultured cells reached 90 percent confluence. Two usual techniques, γ-irradiation and 
mitomycin C (10 mg /ml) treatment, were used for mitotic inactivation (Figure 2.3A). 
 
2.2.4.2. Mouse testicular stromal feeder cells (TSCs) 
TSCs were generated from adult mouse testis tissue that was 4-8 weeks old. After 
digestion of testis, testicular cells were cultured in presence of D-MEM, FBS, MEM 
NEAA solution, glutamine, ß-mercaptoethanol, Pen-Strep and bFGF (Appendix, Table 
14) on T-75 tissue culture flasks at 37 °C and 5% CO2. TSCs cells were passaged to 
new culture flasks after reaching 90 percent confluency. In passage, 2-3 TSC cells were 
used for mitotic inactivation with mitomycin C (10 mg /ml) (Figure 2.3B).  
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Figure 2.3 Cultivation and morphology of different feeders and mESCs in the associated mediums: SNL 
(A), TSCs (B), MEF (C), mESCs (D). 
 
2.2.4.3. Mouse embryonic feeder cells (MEF) 
Embryos (E13-E14) from a pregnant CF-1 mouse were used for MEF preparation. 
Pregnant females were killed by CO2 asphyxia followed by preparation of placenta and 
fetal membranes. Embryos were washed with an HBSS buffer and then intestinal and 
the head of embryos were removed. Subsequently, embryo carcasses were transferred 
to a new plate with an HBSS buffer and the tissue was minced with a syringe, followed 
by digestion with the enzyme solutions, trypsin or collagenase-dispase (1mg/ml) for 15-
20 min. Digestion enzymes were inactivated with 15% serum and the cells pipetted 10 
times to break up the remaining tissue pieces . Digested embryonic cells were grown in 
the present of D-MEM (or KO-DMEM), FBS, MEM NEAA solution, L-glutamine, Pen-
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Strep and ß-mercaptoethanol culture media (Appendix, Table 15) on T-75 tissue culture 
flasks at 37 °C and 5% CO2 (Figure 2.3C).  
MEF cells were passaged when the cultured cells reached up to about 90 percent 
confluence. In passage 3-4, MEF cells were used for mitotic inactivation with γ-
irradiation or mitomycin C treatment. For mitomycin C treatment, cells were incubated 
for 3 h with mitomycin C (10 mg /ml) at 37 °C.   
 
2.2.5. Mouse ES and ES-like cells culture 
mESCs and ES-like cells were cultured in ES media containing KO-DMEM (or DMEM 
high-glucose medium), FBS, MEM NEAA solution, L-glutamine, Pen-Strep, 
mercaptoethanol and LIF (Appendix Table 12). These cells reached confluence about 4-
5 days after initiation of culture. mESCs and ES-like cells were passaged to new MEF 
feeder after being washed with PBS and treated with trypsin-EDTA for 3min. Trypsin-
EDTA was inactivated with 15% of FBS (Figure 2.3D). 
 
2.2.6. Freezing and thawing cells 
Cell freezing medium which included FBS, DMSO and TSCs medium (Appendix, Table 
16) was used to freeze mESCs, ES-like cells, Type I and II cells. Cell plates from Type I 
and II cells were collected by rinsing while for mESCs and ES-like cells were collected 
after trypsinization. The cell pellets were resuspended with a small amount of rest 
culture with gentle shaking. Then 0.5-1 ml appropriate freezing medium was added to 
each vial, followed by quick transport of the vials into an isopropanol freezing container 
and put into a -80°C freezer for 24h. The temperature gradually decreased (1°C per 
minute) in the isopropanol freezing container. After 1 day, frozen vials were transferred 
to a liquid nitrogen tank. To thaw the cells, they were transferred to prewarmed MEF 
medium at 37 °C and after centrifugation, plated to special cell culture medium. 
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2.2.7. Electron microscopy 
For electron microscopy, Type I and II cells were fixed as a pellet with 
paraformaldehyde/ glutaraldehyde in PIPES (Appendix, Table 17). After 5 min, the 
fixative was renewed. Pellets were then post-fixed in OsO4/potassium hexacyanoferrate 
(Appendix, Table 18) for 50 min, rinsed  in the solution of uranylacetat buffer and 
sodium maleate buffer (pH 6.0) (Appendix, Table 19),  and block-stained with uranyl 
acetate (Appendix, Table 20). Following the dehydration through increasing 
concentrations of ethanol (5 min each, 4 x 20 min), the tissue was Epon-embedded 
(polymerization at 60 °C, 24 h). Ultrathin sections (50 nm) were examined with a Zeiss 
EM10. 
 
2.2.8. Flow cytometric analysis 
To remove feeder cells, Type 1 cells, mESCs and ES-like cells were collected and 
incubated for 40 min on gelatine-coated dishes. Staining reaction was performed in 
staining buffer consisting of PBS supplemented with FBS (Appendix, Table 21). After 
determining cell viability by trypan blue staining, cells were resuspended in staining 
buffer and incubated with cell surface primary antibodies-conjugated with fluorochrome 
(APC) (Appendix, Table 6) for 1h. After washing, flow cytometric analysis was 
performed with a BD-FACS Calibur Flow Cytometer. (Cells were analysed by Dr. Heike 
Peterziel, Prof. Angel group, DKFZ, Heidelberg). The experiments were repeated more 
than 3 times and the acquired data was analyzed using BD CellQuest Pro program.   
 
2.2.9. Immunocytochemistry staining 
Cells were cultured in 24 well plates and fixed with 4% paraformaldehyde. After rinsing 
with PBS, samples were permeabilized with 0.1% Triton/PBS (Appendix, Table 22) and 
blocked with 1% BSA/PBS (Appendix, Table 23). After removing the blocking solution, 
the cells were incubated overnight with primary antibodies (Appendix, Table 6). After 
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rinsing, the process was followed by incubation with species-specific secondary 
antibodies which were conjugated with different fluorochromes (Appendix, Table 6). 
Labeled cells were counterstained with 0.2 µg/ml DAPI (4', 6-diamidino-2-phenylindole) 
for 3 min at room temperature and fixed with Mowiol 4-88 reagent. Omission of each 
primary antibody in the sample was used as a negative control for all markers. Labeled 
cells were examined with a confocal Zeiss LSM 700 microscope, and images were 
acquired with a Zeiss LSM-TPMT camera.  
 
2.2.10. Tissue processing for immunohistochemistry (IMH) 
Testis tissue was removed from male animals, which was then washed in PBS and 
fixed in 4% paraformaldehyde for about 24h at room temperature (RT). Dehydrated 
testis were embedded in Paraplast Plus. Testis tissue blocks were cut with a microtome 
at about 10 µm thickness. Sections were mounted on Superfrost Plus slides and stored 
at RT until used. 
All sections were deparaffinized with xylene and rehydrated in an ethanol series prior to 
staining.  After antigen retrieval by heat mediated antigen retrieval (Sodium Citrate 
Buffer, pH 6 or EDTA, pH 8) (Appendix, Table 24) at 95°C for 20 min,  non-specific 
binding was blocked with serum/Triton X-100 in PBS (Appendix, Table 25) and 
immunofluorescence staining continued as explained above. 
For IMH on cryo-sections, the testis tissue was fixed as described above. Dehydrated 
testis tissue was rinsed in PBS and incubated in 10%, 20% and 30% sucrose/PBS for 
12-18 hours followed by embedding of the tissue in Tissue Tek. Frozen blocks were cut 
with a cryostat (Leica CM 3050S) in 12-20 µm sections.  
The sections were mounted on Superfrost Plus glass slides and stored at -20 °C until 
analyzed. All frozen sections were dried at RT for 30 min, followed by 
immunofluorescence staining, which was explained in detail above. 
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2.2.11. RNA extraction and RT-PCR analysis 
For RT-PCR analysis, the expression patterns of different ectodermal, mesodermal and 
endodermal genes (Appendix, Table 8) were studied after spontaneous somatic 
differentiation of ES-like cells. In each sample, total RNA of differentiated ES-like cells 
was extracted by using peq GOLD TriFast reagent. After phenol–chloroform extraction, 
cDNA was synthesized by using M-MLV Reverse Transcriptase kit. For cDNA 
synthesis, 2 µg of total RNA were used, reverse transcribed in a volume of 40 µl and 
finally filled up with water. PCR reactions were performed in single PCR tubes and 
carried out using a Mastercycler gradient machine (Eppendorf, Germany) in a reaction 
volume of 50 µl per sample (Components of each PCR reaction is noted in the 
Appendix, Table 26). The thermal cycling conditions were as follows: initial denaturation 
at 94°C for 3 minutes, followed by 35 cycles with denaturation at 94°C for 30 seconds, 
annealing at primer specific temperatures (Appendix, Table 8) for 30 seconds, 
extension at 72°C for 30 seconds. As last steps, a final extension at 72°C for 10 minutes 
was performed, followed by a cool down to 4°C. The PCR product was analysed by gel 
electrophoresis with an agarose gel in TAE (Tris-acetate buffer EDTA) (Appendix, Table 
27).  The gels were stained with 0.8 μg/ml ethidium bromide and visualized under a UV 
transillumination imager (INTAS, Germany). 
 
2.2.12. Gene expression analyses on the Fluidigm Biomark system  
The Dynamic Array chips (Fluidigm) was used to measure the expression of multiple 
pluripotency and germ cells specific genes including Oct-4, Nanog, Sox2, Klf4, GDF3, 
TDGF1, TERT, CDH1, DAZL, KIT, STRA8, RET, NEUROGENIN, EPCAM,TAF4B, 
TEV5, TBP, PLZF, LHX1, BCL6B and housekeeping gene GAPDH (which was used for 
normalization) (Appendix, Table 9 ) with the different Types of cultured cells such as 
Type I, Type II, TSCs, MEF, ES-like and mESCs. Cells were characterized in very small 
numbers. In each sample, about 50 cells were manually selected from the different cell 
cultures with a micropipette or micromanipulator and immediately frozen and stored at -
80˚C.Each sample was lysed into special lysis buffer containing different components 
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(Appendix, Table 28).  In a process using reverse transcriptase enzyme, mRNA was 
reverse transcribed into cDNA, which was sequence-specifically preamplified in a single 
tube, and the amount of targeted transcripts was quantified using TaqMan real-time 
PCR on the BioMark Real-Time quantitative PCR (qPCR) system. Reverse transcription 
was achieved at 50°C for 15 min using reverse transcriptase enzyme, which  was 
inactivated by heating to 95°C for 2 min. cDNA was denatured at 95°C for 15 s. 
Subsequently, products were pre-amplified at 60°C for 4 min for 14 cycles. The pre-
amplified products were diluted up to 5-fold and then analysed with Universal PCR 
Master Mix and inventoried TaqMan gene expression assays (ABI) in 96.96 Dynamic 
Arrays on a BioMark System. Each sample was analyzed in two technical replicates.  
For analysis purposes, data that were missing in the Biomark system were replaced by 
a Ct of 30 and data were normalized with GAPDH and expression fold change of mRNA 
compared to MEF feeder cells. Analysis was conducted by GenEx software from MultiD 
analysis, Excel and SPSS. 
 
2.2.13. Transplantation 
Type II cells were transfected with enhanced green fluorescent protein (EGFP) gene 
(COP-GFP). For site-specific transplantation into the tubuli seminiferi contorti of the 
testis, approximately 10µl of the donor cell suspension containing 0.5-1x 105 SSCs was 
injected into the rete testis of males SCID NO mice that had been treated with busulfan 
(44 mg/kg) at 6 weeks of age [67]. Adult recipient mice were anesthetized with 
Ketamin(100mg/kg) – Xylazine (20mg/kg) solution. Testis were fixed in paraffin and cryo 
blocks and sections were analysed by confocal microscopy 4-8 week after 
transplantation.sperm cells were kept at -20oC after isolation from the glandula 
epididymidis and fixed on slides. Similarly, sperm cells from EGFP mouse samples 
were isolated from the glandula epididymidis for comparison to our samples. (These 
experiments were performed in Royan Institute, Tehran, Prof. Baharvand´s group). 
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2.2.14. Embryoid Body (EBs) formation 
ES-like cells were cultured in mESCs medium and after expansion were used for EBs 
formation. After trypsinization, ES-like cells were incubated on gelatine coated plates for 
1h to eliminate somatic cells. About 2-3×106 cells were cultured in the medium 
containing KO-DMEM (or DMEM high-glucose), FBS, MEM NEAA solution, L-glutamine, 
Pen-Strep and ß-mercaptoethanol (Appendix, Table 29) in low attachment 10 cm2 
bacterial-grade petri dishes.  EBs spontaneously formed as a suspension culture in 
bacterial culture dishes for 3-4 days. Due to the expression of Oct-4-GFP in the ES-like 
cells, generated EBs also expressed Oct-4-GFP. 
 
2.2.15. Neuronal differentiation 
Neuronal differentiation was induced in three stages. Stage 1, which is related to EB 
formation, is discussed above. Then in stage 2, for generating neuronal progenitor cells, 
EBs were cultured in the medium containing DMEM-F12, NEAA, L-Glutamin, N2, FGF 
and  RA (Appendix, Table 30) as suspension in low attachment 10 cm2 bacterial-grade 
petri dishes for additional 6 days . FBS concentration was decreased to 10% (days 1-2), 
5% (days 3-4) and 3% (days 5-6) in the second stage. In stage 3, approximately 10 
days after initiation of suspension culture, EBs were plated on poly-L-ornithine coated 
wells of 6 or 24-well tissue culture plates in the Neurobasal medium contain NEAA, L-
Glutamin, B27, N2 and FBS (Appendix, Table 31) for additional 10 days. This condition 
medium allowed maturation and development of neuronal progenitor cells (Figure 2.4A). 
 
2.2.16. Cardiomyocyte differentiation  
Similar to neuronal differentiation, cardiomyocyte differentiation was induced in three 
stages. Stage one was similar to neuronal differentiation. In stage 2, for spontaneous  
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Figure 2.4: Differentiation of mature neurons and cardiomyocyte cells from ES-like cells. According to 
both differentiation protocols, mature neuron and cardiomyocyte cells were obtained after EBs formation. 
For neuronal differentiation, EBs were exposure with RA and low concentration of FBS (A), while a high 
concentration of FBS without RA treatment was used for cardiomyocyte differentiation (B).   
mesodermal differentiation, EBs were grown in medium containing DMEM-F12, NEAA, 
L-Glutamine, N2, FGF and  FBS (Appendix, Table 32) as suspension in low attachment 
10 cm2 bacterial-grade petri dishes for a further 8 days. In the final stage, in order to 
receive beating cells, EBs were plated in1% gelatine-coated wells of 6 or 24-well tissue 
culture plates under the same medium used in stage 2 (Appendix, Table 32). 
Subsequently, the number of beating clusters and the number of beats per minute were 
counted at the end time of the final stage. In addition, after the EBs were plated, 
differentiated cells were used for RT-PCR analysis of mesodermal and endodermal 
lineage genes (Figure 2.4B).    
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2.2.17. Teratoma assay 
After trypsinization of ES-like cells, dissociated cells were replated on 0.1% gelatine 
coated plates in mESCs medium at 37 °C and 5% CO2 for about 1 h followed by 
collecting the supernatants. After centrifugation cells were resuspended in 130 µl PBS 
and 70 µl matrigel on ice. About 2-3 х 106 cells were injected subcutaneously into 7-
week old SCID-beige mice and checked 3 times per week for tumor growth. (The 
experiment was performed in Royan Institute, Tehran).  
 
2.2.18. Electrophysiology 
Whole-cell current clamp recording was established using an EPC-9 amplifier and 
acquired using the Patch Master software. All recordings were made from the somata of 
visually identified differentiated neurons (Leica DM LFS Dodt-contrast videomicroscopy, 
63x water immersion objective). Patch electrodes were pulled from thick-walled 
borosilicate glass (2 mm OD, 1 mm ID) and were filled with an intracellular solution 
(Appendix, Table 33).The direct current resistance of the electrodes was 4-6 MΩ. The 
cells were seeded on glass coverslips (5mm) and transferred to the recording chamber. 
During recording, the slices were perfused with 34-36°C 1x aCSF extracellular solution 
buffer (Appendix, Table 34). Data analysis was performed using Igor Pro 6 software 
(WaveMetrics, Portland, OR). (Patch analysis was performed by Daniel Nunes, Prof. 
Kuner group, Neuroanatomy Institute, Heidelberg). 
 
2.2.19. Alkaline phosphatase assay 
ESCs and ES-like cells were stained with NBT/BCIP in TMN-Puffer, pH 9.5 (NBT:4-
Nitro blue tetrazolium chloride, solution; Roche: 11383213001; BCIP: 5-bromo-4-chloro-
3-indolyl-phosphate; Roche: 11383221001). 
This reaction was stopped using deionized water and fixed with 4% PFA. After washing, 
samples were embedded with Kaiser's glycerol gelatine and stained cells were 
examined with a light microscope.  
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2.2.20. Production of chimeric mice 
Generation of chimera was used for the examination of differentiation potential of ES-
like cells during in-vivo. Blastocysts were collected at 3.5 days post-coitus from 
superovulated female NMRI mice in the basic M2 medium. About10–15 single-cell ES-
like cells were transferred into each blastocyst. Approximately 10 injected embryos were 
surgically transferred into the uterine horns of in pseudo-pregnant NMRI recipient 
female mice. Chimera mice were usually identified by coat colour. (This experiment was 
performed by Dr. Yaser Tahamtani and Behroz Asgari, Prof. Baharvand´s group, Royan 
Institute, Tehran). 
 
2.2.21. Statistical analysis 
All the experiments were replicated at least 3 times. The average expression of genes 
in groups was calculated, and groups were evaluate using One-way analysis of 
variance (ANOVA) followed by the Tukey's post-hoc tests (T-Test). 
Expression of genes was compared with the non-parametric Mann-Whitney’s test. The 
variation between groups was considered statistically reliable if a value of P < 0.01 was 
acquired. 
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Chapter 3 Results 
 
3.1. In-vivo and in-vitro identification of different types of germ cells of the mouse 
testis 
3.1.1. In-vivo identification of germ cells of the mouse testis 
  
3.1.1.1. Germ cells markers are expressed in the mouse testis 
In order to discriminate the local expression of different germ cells markers and thereby 
understand germ cell marker expression patterns during germ cell differentiation in the 
testis of adult mice, we performed immunohistochemical (IMH) analysis on 10 µm thick 
sections of the testicular parenchyma. 
IMH confirmed the expression of all the known germ cell markers (Oct4, VASA, DAZL, 
PLZF, N-Myc) which were all expressed in specific cell types and compartments of adult 
mouse testis sections (Figure 3.1, Table 3.1). 
We showed, that in addition to the strong nuclear Oct4 staining in a few SSCs directly in 
the basement stem cell compartment, the presence of nuclear Oct4 signals with much 
lower intensity in progenitor cells and spermatocytes above the stem cell layer (Figure 
3.1A). In the upper part of the epithelium, the Oct4 signal was down-regulated in 
spermatids (Figure 3.1A). We observed a cytoplasmic expression of VASA and DAZL 
protein in cells above the basement membrane through to the middle part of the 
testicular lumen, not only staining spermatogonia, but also with a lower intense 
expression in spermatocytes (Figure 3.1B and C).  Similar to Oct4, the transcription 
factor PLZF was detected only in the basal compartment of the testicular tubules 
(Figure 3.1D). N-Myc protein was expressed only in the middle part of testis luminal 
region (Figure1E). We also detected cytoplasmic expression for Klf4 which was 
localized in cells starting from above the basement membrane (data not shown) through 
to the differentiated part of the seminiferous tubule.   
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Figure 3.1: Immunohistochemistry documented expression of Oct4 (A1-A4), VASA (B1-B4), DAZL (C1-
C4), PLZF (D1-D4) and N-Myc (E1-E4) in adult mouse testis sections (A, B, C). Oct4, PLZF and N-Myc 
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displayed a nuclear staining, while VASA and DAZL had a cytoplasmatic staining. Only the staining 
pattern for PLZF was restricted to the SSC stem cell compartment, while Oct4 signals were strongest in 
the basal stem cell compartment, but also present in the differentiating cells of spermatogenesis. Positive 
VASA staining signals were weak in the basal compartment and stronger in the differentiating cells. DAZL 
revealed a more homogeneous staining pattern in SSCs, spermatocytes and spermatids. N-Myc signals 
were confined to the differentiating cells. Scale bar is 10µm. 
 
 
3.1.1.2. Co-localization of germ cells markers in the testis section 
 
To answer the question of whether germ cell markers show any co-expression during 
in-vivo differentiation, we performed co-staining with the different germ cell markers 
described above. 
Our analysis demonstrated a high expression of the germ stem cell marker PLZF and 
Oct4, which were both localized in cells directly above the basement membrane in the 
stem cell compartment of testicular tubules (Figure 3.2, Table 3.1). The PLZF signal 
was present in more SCCs in comparison to Oct4, which was restricted to a lower 
number of SSCs (Figure 3.2A1-A4). This analysis was quantified for 146 parts of  
seminiferous tubule from 3 testis sections. 
In cross section of 7 week old mouse testis, we observed that all Oct4 positive cells 
were positive for PLZF cells but in contrast, about 40 percent of PLZF positive cells 
were positive for Oct4 (Figure 3.2A1-A4). 
We also confirmed that PLZF positive cells showed low expression of VASA (Figure 
3.2B1-B4) and N-Myc (Figure 3.2C1-C4). These results might confirm that the 
expression of germ cells markers Oct4, PLZF, VASA, DAZL and N-Myc might be 
essential during spermatogenesis.   
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Figure 3.2: All of Oct4 positive cells in the basement membrane of seminiferous tubules were positive for 
PLZF while only about 40 percent of PLZF positive cells were positive for Oct4 (A1-A4). In the cross 
section of testis, PLZF positive cells showed low expression for VASA (B1-B4) and VASA positive cells 
were negative for N-Myc (C1-C4). Scale bars: 50µm. 
 
3.1.1.3. No co-localization of Sertoli cells markers with germ cells markers 
To answer the question of whether Sertoli cell markers show any overlap expression 
with germ cells markers during in-vivo differentiation, we performed co-stainings for 
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different germ cells markers including DAZL, VASA, N-Myc with sertoli cell markers 
Sox9 and VIMENTIN.  
 
  
 
 
 
 
 
 
 
 
 
 
Table 3.1: Immunohistochemistry shows distribution and signal density for different markers in the 
seminiferous tubules of testis. 
 
The expression of Sox9 and VIMENTIN intermediate filament (IFs) proteins was 
observed in intratubular cells of the 7-week-old mouse testis (Figure 3.3). The nuclear 
staining of SOX9 was restricted to Sertoli cells, which were co-localized with 
VIMENTIN-positive cytoplasmatic stainings. This is typical for Sertoli cells bridging the 
germinal epithelium from the basal stem cell compartment towards the lumen (Figure 
3.3, Table 3.1). 
We also observed that all Sox9 positive cells were positive for VIMENTIN and negative 
for germ cells markers DAZL, VASA and N-Myc protein (Figure 3.3B-D, Table 3.1). 
Sertoli cells regulate the spermatogonial cell functions in the male gonad. Sox9 
expression was limited to the Sertoli cells of testis and has been used as a specific 
marker for the identification of Sertoli cells in rat testis [140]. 
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Figure 3.3: Sertoli cells were negative for germ cell markers. Immunohistochemistry showed expression 
of the Sertoli cell marker VIMENTIN (A1-A4) and Sox9 (B1-B4) in the testis sections. Sox9 positive cells 
were positive for VIMENTIN (B1-B4) and negative for germ cell markers DAZL (C1-C4) and N-Myc (D1-
D4). Scale bars: A 10µm, B-D 50µm.   
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3.1.2. In-vitro identification of mouse germ cells  
 
3.1.2.1. Isolation of different cell populations from testicular cells of Oct4-GFP 
transgenic mice 
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Figure 3.4: Expression of Oct4-GFP in the seminiferous tubule of Oct4-GFP reporter transgenic mouse 
seminiferous tubules of neonate and adult mouse testis. In the adult mice, the number and signal density 
of Oct-GFP was lower in comparison to neonate mice (A and B). Typical tightly packed morphology of 
Type I cells obtained from neonate mouse testicular tissue were observable during initial culture with 
some colonies positive and some negative for Oct4-GFP (C). Morphology of Type I cells in the adult 
mouse was similar to neonate GSCs (D). Type I colonies were grown on MEF feeder (E). Scale bar: 50 
µm.  
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Figure 3.5: Microscopic observation of the expansion of Type II cells on TSCs (A, B) and SNL (D) 
feeders. Cell clusters were observable under the spermatogonial culture conditions(C). Type II cells were 
generated from control GFP mice and expanded for long-term culture on SNL feeder (E-F).  Scale bar: 50 
µm. 
 
We used the Oct4-GFP transgenic mouse model for the isolation of different cell types 
of the testis. An Oct4-GFP signal was clearly observable in the seminiferous tubules of  
neonate mouse testis but it was not same in the adult mouse (~6 months old). 
In the adult mice testis, the number and signal density of Oct-GFP was lower than in 
neonate mouse testis (Figure 3.4A and B). After mild digestion of the testicular tissue 
with a combination of the enzymes collagenase/dispase, the seminiferous tubules were 
almost separated from each other. A single cell suspension was obtained after further 
enzymatic digestion and transferred into mGSC medium.  Somatic cells started to grow 
within 2-10 days after the cultures were initiated (both were obtained from neonate and 
adult mice with mGSC culture medium). During initial culture of both neonate and adult 
mice, two different morphological populations of germ cells were observable, which will 
be named Type I and II cells from this point on (Figure 3.4D, E and Figure 3.5).  
Type I cells were observable during the initial culture of both neonate and adult mice 
between 2 or 14 days after initiation of the primary testis cultures with GS medium 
(Figure 3.4C). Type I cells were round, compact cells with a size of about 12 μm2 grew 
in a tightly packed (lumpy colony) formation during long-term culture. In the beginning, 
some Type I cells expressed low levels of Oct4-GFP (some were negative for Oct4-
GFP) (Figure 3.4C), while this signal was completely down-regulated during long-term 
culture (Figure 3.4D and E). After conversion of these cells to a pluripotent state, the 
Oct4-GFP signal emerged again (this conversion is explained later in more detail in the 
section regarding pluripotency). In comparison to Type I cells, Type II cells were usually 
small round cells with a size about 30 μm2 which loosely connected to each other. 
These grew as a flat colony formation, but did not show any three-dimensional growth 
pattern (Figure 3.5). In primary culture, Type II cells emerged about 2-3 weeks in 
neonate mice and 3-7 weeks in adult mice. These cells did also not express the Oct4-
GFP signal at any time during culture.  
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Type II cell colonies showed no strong attachment neither between themselves nor with 
the somatic feeder cells. These cells were easily separated from each other by gentle 
pipetting. 
 
3.1.2.2. Characterization of different germ cells populations 
 
3.1.2.2.1. Long term culture and expansion of Type I and II cells 
As mentioned above, Type I and II cells emerged on primary somatic testicular feeder 
cells for a short period of time (Figure 3.4 and 3.5).The cells were selected with a 
micromanipulator or manually hand-picking from primary culture. Different types of 
feeders such as MEF, TSC and SNL feeder (interrupted cell division with either γ-
irradiation or Mitomycin C treatment) were tested for the expansion of Type I and II 
cells. Our analysis showed that Type I cells disappeared about 2 weeks after initiation of 
the culture on neonate TSCs (Figure 3.4C1-C3), while the supportive MEF feeder layer 
provided an ideal environment for long-term expansion of these cells (Figure 3.4D and 
E).   
Similarly, Type II cells grew for more than 5 weeks on neonate TSCs and 10 weeks on 
old TSCs feeder (Figure 3.5A and B). In some parts of the testicular culture, we also 
observed aggregation of somatic cells which displayed a strong cell interaction while 
cell dissociation was difficult (Figure 3.5C). The SNL feeder layer is an immortalized cell 
line derived from MEF cells transfected with the murine LIF gene [83]. This type of 
feeder provides an ideal support for the long-term expansion of these cells from 
neonate and adult mice (Figure 3.5D-F). Both Type I and II cells were cultured in mouse 
GSCs medium for more than one year and passaged every 3-4 weeks on new feeder 
cells. Although Type II cells could be expanded on SNL and primary TSC feeders, these 
feeders were not suitable for cultivation of Type I cells.  
 
3.1.2.2.2. Electron Microscopic analysis of Type I and II cells 
Electron microscopic results indicated that unlike Type I cells, Type II cells showed a 
different morphology compared to in-vivo SSCs that are located on the basement 
membrane of the seminiferous tubule. 
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Figure 3.6: Electron microscopic results for Type I (A, B) and Type II (C, D) cells. Nucleus/cytoplasm ratio 
in the Type I cells was higher than Type II cells. Scale bar: 2 µm. 
 
In contrast, Type I SSCs have a similar morphology in comparison to SSCs in-vivo 
which possess a large nucleus and small cytoplasmic rim (high nucleus/cytoplasm ratio) 
(Figure 3.6A and B), while in Type II cell’s nucleus/cytoplasm ratio was low and they 
were packed with vesicles and other cell organelles (Figure 3.6C and D). 
 
3.1.2.2.3. Immunocytochemistary of in-vitro germ cells 
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Figure 3.7: Immunocytochemistry results showed that Type I cells express the germ cells markers DAZL 
(A1-A4), VASA (B1-B4), PLZF (C1-C4), GFRa1 (D1-D4) and Oct4 (E1-E4). 
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We isolated Type I cells from neonate and adult mouse testis. The cells were passaged 
about 4 weeks after first isolation in the GS media and MEF feeder.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Type I cells were negative for Klf4 (A1-A4), Nanog (B1-B4) and Sox2 (C1-C4). Scale bar 
50µm. 
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In passages 3 and 12, Type I cells were cultivated in 24 well plates on cover-slips with 
MEF feeder cells and used for immunocytochemistry. 
Immunocytochemistry analysis showed that Type I cells displayed a high expression for 
germ cells markers VASA, DAZL, PLZF, GFRa1 and Oct4 (abcam) (Figure 3.7).  
On the other hand, they showed low expression for Klf4, Nanog, Sox2, Oct4 (Santa 
Cruz) and did not express VIMENTIN (confirmed in double staining with VASA) (Figure 
3.8, Table 3.2).  
Immunocytochemistry results showed that during in-vitro culture of PLZF positive Type I 
cells, these cells were also positive for VASA (Figure 3.7B-C). In contrast, PLZF positive 
cells in the testis were negative for VASA protein (Figure 3.2B1-B4).  
 
 
Figure 3.9: Immunocytochemistry showed that Type II cells express Klf4 (A1-A4), N-Myc (B1-B4) and 
Sox2 (C1-C4). 
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Immunocytochemistry for Type II cells confirmed that unlike Type I cells, Type II cells 
were negative for VASA and DAZL, while these cells clearly expressed Klf4 and N-Myc, 
Oct4 (Abcam) and Sox2 proteins (Figure 3.9, Table 3.2). Oct4 was expressed in Type II 
cells but this level was lower than in Type I cells. Type II cells also expressed a low 
level of GFRa1, PLZF, Nanog and Sox9 protein (data not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2: Comparison of immunostaining results for cells Type I, II cells TSCs and testis sections. Type I 
cells have low expression for Sox9 and Sox2 and in addition, were negative for Klf4, N-Myc and 
VIMENTIN. Type II cells expressed markers Klf4, N-Myc, VIMENTIN and Oct4. On testis sections, no IMH 
signals for Nanog and Sox2 were detected. 
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3.1.2.2.4. Infertile mouse model and transplantation of germ cells into testis 
 
Because SSCs possess no highly selective marker for their identification, the functional 
characterization of putative SSCs in infertile mice is an ideal model to characterize the 
ability of the transplanted cells to produce sperm. To induce infertility, the nod SCID 
mice were treated with busulfan (40mg/kg) for 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Busulfan injection to SCID mouse model. Decreased size of testis (A) and destroyed 
endogenous spermatogenesis (C) after busulfan injection. Hematoxylin-Eosin staining analysis for normal 
testis (B) and busulfan injected testis (C). Spermatogenesis was observable in normal testis section (B). 
 
4 weeks, this is selectively toxic for germ stem cells (Figure 3.10). Morphological 
analysis of the treated mice testis indicated changes in size (testis became much 
smaller) and histological analysis documented destroyed endogenous germ stem cells 
in the seminiferous tubules of the testis treated with busulfan (Figure 3.10). In contrast, 
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Hematoxylin-Eosin staining analysis for cross-sections through seminiferous tubules of 
normal testis revealed absolutely normal spermatogenesis (Figure 3.10).   
As we mentioned above, Type I cells clearly expressed the usual germ cells markers, 
while Type II cells partially expressed germ cells markers but were positive for N-Myc, 
Klf4 and Oct4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: Transplantation of Type II cells in testis. About 1month after transplantation of GFP labeled 
Type II cells, localization of Type II cells in the basal compartment of infertile testis was observable (A1-
A3). About 3 months after transplantation of Type II cells, GFP sperm was observable in the epididymis of 
testis (B1-B3). GFP positive sperms were observed in the epididymis of control testis (C1-C3).  
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Because Type II cells only had low expression for some of the typical germ cell 
markers, we analysed the functional potentiality of Type II cells by transplantation of 
these cells into infertile mouse model. To trace cells after transplantation, we used an 
actin promoter GFP mouse model (“green mice”) or transfected Type II cells with 
lentiviral particles of COP-GFP construct in order to produce GFP positive sperm. 
For this experiment, Type II cells were isolated from “green mice” and used for 
transplantation after expansion on SNL feeder. We observed that even after about 8 
months after cultivation of Type II cells, these cells still expressed GFP on SNL feeder 
(Figure 3.5E-F). 
We diluted about 100 000 Type II cells in 10µl of DMEM and transplanted the cells into 
the rete testis of the busulfan-treated infertile mouse model. About 4 weeks after 
transplantation, the histological analysis revealed that that GFP positive Type II cells 
were located in the basal compartment of seminiferous tubules of the busulfan-treated 
recipient mouse testis (Figure 3.11A1-A3). About 3 months after transplantation, we 
observed GFP-positive sperm in the epididymidis of the recipient testis (Figure 3.11B1-
B3). No GFP positive cells were detected in the non-transplanted group confirming the 
specificity of this method. 
 
3.2. Pluripotency of testicular cells 
3.2.1. Generation of ES-like cells from testicular culture 
Type I and II cells were cultivated in GS media and passaged every 3-4 weeks for long-
term culture. As mentioned previously, some of Type I cells expressed low level of 
Oct4-GFP in the beginning of the culture (Figure 3.4C1-C3) but this expression 
completely down-regulated during long-term culture (Figure 3.4D and E). In contrast, 
Type II cells did not express any Oct4-GFP signal at any point during cultivation. We 
performed more than one year of cultivation (more than 15 successful repeated 
expansions) for both types of neonate and adult mouse testis cells.  
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Figure 3.12: Generation and expansion of ES-like cells that express Oct4-GFP. Generation of ES-like 
cells in the mGSC medium (A1-A2). Expansion of ES-like cells in mouse ESCs medium (B1-B3). 
 
For generation of ES-like cells, we directly isolated Type I and II cells in primary culture 
or selected the colonies after subculture of supernatants from primary culture 
(supernatants were collected about two days after initiation of culture from neonate 
mouse testis). Unlike Type II cells, Type I cells grew and expanded on MEF feeder in 
mGSC media which contained GDNF, FGF, EFG and LIF (Figure 3.4D and E). During 
long-term culture for Type I cells, we rarely found colonies that were similar to mESCs 
(ES-like cells) or cultured epiblast cells that clearly express a high level  of Oct4-GFP 
(Figure 3.12A1-A2). Typical ES-like cell colonies have a packed spindle to round-
shaped morphology with smooth borders (Figure 3.12A1-A2). Moreover, as mentioned 
before, they displayed a high intensity of the Oct4-GFP signal (Figure 3.12A1-A2). 
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At the same time as the Type I cells were cultured, we cultured Type II cells in mGSC 
media and MEF feeder. We observed that Type II cells did not expand on MEF feeder 
and we therefore used SNL feeder for expansion of Type II cells. Under the same 
culture condition used for Type I cells, we did not observe any Oct4-GFP colonies in 
Type II cells.  
 
3.2.1.1. Time window for generation of ES-like cells from testis 
As we mentioned above, ES-like colonies were generated only in Type I cells. ES-like 
colonies were successfully established in 5 of 15 experiments (33%). We observed a 
critical time after initiation of culture (about 40-125 days after initiation of culture) for 
reprogramming of Type I cells (Figure 3.13). ES-like cell colonies were observed in days 
41, 79, 81, 110 and 125 after initiation of culture from the neonate (1-week-old) and 
adult (7-week-old) mouse testis (Figure 3.13). We did not observe any ES-like colonies 
after (125 days) and before (40 days) this time period (Figure 3.13). We cultured 
generated ES-like colonies that express Oct4-GFP under mouse ES medium conditions 
with DMEM /15% FBS and LIF (Figure 3.12B1-B3). The ES-like colonies were 
passaged 1:5–1:8 for more than 15 times following trypsin digestion, with an estimated 
doubling time of 48-72 h. The ES-like cells still expressed Oct4-GFP after long term 
cultivation (Figure 3.12B1-B3). 
The cells preserved their undifferentiated state in multiple passages and demonstrated 
clonal growth from single cells. The established ES-like colonies were successfully 
expanded, cryopreserved and thawed with no loss in proliferation or differentiation 
capacities.  
While ES-like colonies could grow and expanded on mESCs medium, we observed 
Type I cells could not be expanded in this culture condition in 5 experiments (data not 
shown). As mentioned, Type I cells in the initiation of culture expressed a low level of 
Oct4-GFP and this signal was lost during long-term culture. It seems that during 
reprogramming and after conversion of Type I cells to a pluripotent state, the Oct4-GFP 
signal emerged again. 
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Figure 3.13: Protocol for the generation of ES-like cells from mouse testis.  
After trypsinization of ES-like colonies, single cells were obtained from which we cultured new ES-like cell 
colonies under mouse ES cell medium condition. ES-like cells colonies were grown in mESCs media and 
were passaged every 3-4 days (A). ES-like cells were only generated in a time window between 40-125 
days (in days 41, 79, 81, 110 and 125) after initiation of culture (B).The appearance of ES-like cells was 
completely independent from a higher density of the cultures as suggested by Ko et al [64]. 
 
3.2.1.2. Characterization of ES-like cells 
3.2.1.2.1. Gene expression analysis for Type I, II, ES-like cells, mESCs and feeder 
cells  
In our experiments with Fluidigm Real-Time RT-PCR, we examined whether Type I and 
II cells express germ cells and pluripotency markers and compared the gene 
expressions patterns between mESCs, ES-like and feeder cells.  
As first step, we compared the pluripotency- and germ cell-associated  gene expression 
pattern between Type I and II cells obtained from mice of different ages (after picking up 
in the initiation phase of culture from neonate, 2, 4, 8, 10 week old mice), ES-like cells,  
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Figure 3.14:  Fluidigm Real-Time PCR analysis for germ cells and pluripotency markers.  
mRNA characterization of germ cell genes between Type I cells (after selection in the initiation of 
culture=A, neonate mouse=B, 2weeks mouse=C, 4 weeks=D, 8 weeks mouse=D), Type II cells (Neonate 
mouse= F, 10 weeks mouse=G), ES-like cells=H, mESCs=I, TSCs feeder=J, MEF feeder=K.  
(A) RT-PCR analysis showed the expression of DAZL, VASA, Ret, EPCAM, KIT, SCP1, TERT, BCL6B, 
ETV5, LHX1, PLZF and TAF4B in Type I cells was significantly higher than in ES-like, mESCs, TSCs and 
MEF while (B) the expression of some pluripotency markers such as Nanog, LIN28, TDGF1, DPPA5, 
NODAL and GDF3 in the ES-like significantly was higher than Type I, TSCs and MEF cells. There was no 
significant regulation for genes Oct4 and SOX2 in Type I, ES-like and mESCs, while these genes were 
significantly were higher than TSCs and MEF. Y-axis shows expression fold change of mRNA in 
comparison to MEF feeder cells. Significance difference between ES-like and ESCs with Type I, Type II 
and MEF cells is at least P<0.01, t-test. 
 
 
mESCs, TSCs and MEF (Figure 3.14). We observed that the expression of DAZL, 
VASA, Ret, EPCAM, Kit, Scp1, Tert, Stra8, IHH and the transcription factors Bcl6B, 
Etv5, Lhx1, PLZF and Taf4B in Type I cells was significantly higher than in the other 
groups (p<0.01) (Figure 3.14A). We also confirmed that the expression of pluripotency 
markers such as Nanog, Lin28, TDGF1, Dppa5 and Nodal was significantly down 
regulated in Type I and II cells and up regulated in the ES-like cells (p<0.01)  (Figure 
3.14B). We did not observe any significant regulation between Type I, II and ES-like 
cells for Oct4, Sox2 and GDF3 gene expression, while these genes showed a higher 
significant expression than feeder cells (p<0.01) (Figure 3.14B). 
 
3.2.1.2.2. Expression of surface markers in Type I, II, ES-like, mESCs and testis 
cells 
We used flow cytometry analysis to investigate the expression of some of the known 
surface germ cells markers including CD9, CD29, CD49, GFRa1, CD117 in Type I, II, 
ES-like cells, mESCs and testis cells (Figure 3.15).  
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Figure 3.15: Flow cytometry analysis for some surface germ cells markers in cells Type I, Type II, ES-like 
cells and mESCs. Expression of CD9, CD29, CD49, E-Cadherin, GFRa1 and CD117 in Type I cells is 
higher than in Type II cells. The expression of E-Cadherin and GFRa1 was down-regulated in ES-like 
cells in comparison to Type I and II cells. 
 
In this experiment, Type I and II cells were isolated after expansion on feeders in mGSC 
medium. mESCs and ES-like cells colonies were used after expansion in ES cell 
standard medium. Testis cells were directly isolated from adult mice (5, 6 and 7 weeks) 
after enzymatic digestion. 
Flow cytometry analysis in Type I cells demonstrated that expression of CD9, CD29 and 
CD49 was significantly higher than in testis cells (p<0.01) (Figure 3.15) and the 
expression of CD29, CD49, E-cadherin and GFRa1 was significantly higher than in 
Type II cells (p<0.01) (Figure 3.15). Similarly, the expression of CD9 in Type II cells was 
significantly higher than in testis cells while the expression of CD49, E-Cadherin, 
GFRa1 and CD117 in testis cells was significantly higher than in Type II cells (Figure 
3.15). 
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We did not observe any significant difference for markers CD9, CD29, CD49 between 
Type I cells and ES-like cells, while the expression of GFRa1 and E-Cadherin in Type I 
cells and testis cells was significantly higher than in mESCs and ES-like cells (p<0.01) 
(Figure 3.15). In addition, we did not observe any significant difference for markers 
CD9, CD29, CD49 between ES and ES-like cells, while the expression of GFRa1 and 
E-Cadherin in the ESCs was higher than in ES-like cells. We confirmed that C-Kit 
expression in the ES-like cells was significantly higher than in all other groups (p<0.01) 
(Figure 3.15). 
 
3.2.1.2.3. Embryoid Body (EBs) formation of ES-like cells 
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Figure 3.16: In-vitro differentiation of ES-like cells into EBs.  Expression of Oct4-GFP in EBs from ES-like 
cells which were generated from Oct4-GFP transgenic mouse testis (A1-A3). Down-regulated expression 
of Oct4-GFP after treatment with 3µM RA (B1-B3). Beating differentiated-ES-like cell areas were 
completely negative for Oct4-GFP (C1-C3). 
 
We used spontaneous differentiation during EBs formation to demonstrate the 
pluripotency of ES-like cells, and also performed direct differentiation to neuronal and 
cardiomyocyte phenotypes. Similar to mESCs, ES-like cells could form EBs in low 
attachment bacterial dishes (Figure 3.16). EBs formed during 4 days in mESCs media 
without LIF and expressed high levels of Oct4-GFP (Figure 3.16A1-A3). For further 
neuronal differentiation, EBs were cultured in the presence of retinoic acid (RA) and low 
concentration of FBS for 6 days (Figure 3.16B1-B3) , while for cardiomyocyte 
differentiation EBs were cultured in a high concentration of FBS. We observed down 
regulation of Oct4-GFP expression in the EBs, about 2 days after initiation of the 
differentiation with RA (Figure 3.16B1-B3). Similarly, we showed beating differentiated-
ES-like cell areas which were completely negative for Oct4-GFP (Figure 3.16C1-C3).  
 
 
3.2.1.2.4. In-vitro neuronal differentiation of ES-like cells (ectodermal lineage) 
In order to promote directed differentiation of ES-like cells into a neural fate, we cultured 
EBs in the presence of 3µm RA and low percentage of FBS.  
For neuronal differentiation, EBs were cultured in neurobasal medium with B27 and N2 
supplement on poly-L-ornithine coated dishes. Neuronal morphology was observable  
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Figure 3.17: In-vitro differentiation of ES-like cells to a neuronal fate after RA treatment. After 
differentiation, ES-like cells expressed markers Map-2, Tuj1, NeuN, Pax6 and GFAP (A, B, C). We 
observed that Map-2 positive cells were positive for Tuj1 (A1-A3) and the transcription factors Pax6 and 
NeuN (B1-B3 and C1-C3). A few GFAP positive cells expressed NeuN (D1-D3).   
 
about 3 days after plating and about 10 days after plating immunofluorescence staining 
of the typical neuronal markers such as Map-2 (Figure 3.17A2), Tuj1(Figure 3.17A3-D3 
and F3), Nestin (Figure 3.17B2), glial fibrillary acidic protein GFAP (Figure 3.17C2), 
NeuN (Figure 3.17D2 and E2) and the neuronal transcription factor Pax-6 (Figure 
3.17F2). With double staining immunocytochemistry, we observed that Tuj-1 positive 
cells were also positive for Map-2 (Figure 3.17A1-A4), Nestin (Figure 3.17B1-B4), NeuN 
(Figure 3.17D1-D4) and Pax6 (Figure 3.17F1-F4), while GFAP positive cells were 
negative for Tuj1 (Figure 3.17C1-C4) and NeuN (Figure 3.17E1-E4). As mentioned, RA 
induces neuronal differentiation and suppresses Oct4 expression in the EBs during 
neuronal differentiation (Figure 3.16B1-B3). 
 
3.2.1.2.5. In-vitro differentiation of ES-like cells into endodermal and mesodermal 
lineage (cardiomyocyte/beating cells) 
For mesodermal and endodermal lineage differentiation, ES-like cells were used for EB 
formation in a high concentration of FBS serum. After plating of differentiated EBs, cells 
were used for analysis of mesodermal and endodermal differentiation by mRNA 
expression (Figure 3.18A) and functional cardiomyocyte analysis (Figure 3.19). About 5-
10 days after plating of EBs, we observed areas with contractions of beating cells 
(cardiomyocyte cells) (Figure 3.16C1-C3) which started in the late stage of cultured 
EBs. We measured the number of beating areas in each well of a 6-well plate and the 
number of beating contractions per minute in each beating area. We observed about 14 
(±3) beating areas per well of the 6-well plate and 87 (±36) beating contractions per 
minute. As mentioned before, ES-like cells expressed Oct4-GFP and we observed 
down-regulation of Oct4-GFP during cardiomyocyte differentiation. The beating area 
was completely negative for Oct4-GFP (Figure 3.16C1-C3). RT-PCR analysis revealed 
that EBs and differentiated cells expressed genes typical for vascular, epithelial and 
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hepatic or myogenic cells, early mesoderm and cardial-differentiated cells, while 
differentiated neuronal EBs were negative for MyoD, Myf5, AFP and mESCs and ES-
like cells were negative (or showed only low expression) for PEPCAM1, Myf5, MyoD, 
Islet1 and FLK1 (Figure 3.18A) . 
  
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18: RT-PCR and alkaline phosphatase analysis: 
RT-PCR analysis for expression of mesodermal and endodermal lineage genes from mESCs, mGPS, CF-
1 MEF cells and early spontaneous differentiated EBs (6-10 days after plating of cardiomyoctes EBs), EB 
formation of cardiomyoctes (EB-CD) cells in day 10, EBs formation for neuronal cells (EB-ND)  in day 10 
and water control (A).Type I cells were partially positive for alkaline phosphatase (B) while ES-like cells 
were positive for alkaline phosphatase (C). Scale bare 50µm.   
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3.2.1.2.6. ES-like cells are positive for pluripotency markers and alkaline 
phosphatase 
As we mentioned above, we isolated Type I cells from Oct4-GFP transgenic mice during 
a critical time-window after initiation of culture and converted these cells to ES-like cells 
that express high level of Oct4-GFP.  
ES-like cells were passaged 1:5-1:8 more than 15 times following trypsin digestion. We 
observed that the ES-like cells maintained their undifferentiated state which 
demonstrated the effectiveness of clonal growth from single ES-like cells under MEF 
feeder layer and LIF cytokine conditions.  In order to characterize the undifferentiated 
state of ES-like cells, we performed alkaline phosphatase (AP) staining (Figure 3.18 B 
and C) and immunocytochemistry for pluripotency markers Oct4 from Abcam (Ab), Oct4 
from Santa Cruz (SC), Nanog, Sox2 and Klf4 (Figure 3.19).  
While Type I cells were partially positive for AP which display a more faint staining, ES-
like cells showed a similar intense staining for AP in comparison to mESCs (Figure 18B 
and C).  
In our experiment, we observed that Type I cells were positive for Oct4 (Ab) and 
negative for Oct4 (SC) while both proteins were expressed in ES-like cells. This 
observation might confirm different isoforms of Oct4 protein in mouse cells. Similarly, 
while Type I cells were negative for Nanog and Klf4 or showed a low expression of 
Sox2, ES-like cells clearly expressed these pluripotency markers (Figure 3.19).     
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Figure 3.19:  Immunocytochemistry results showed that ES-like cells express pluripotency markers  Oct4 
from Abcam (A1-A4), Oct4 from Santa Cruz (B1-B4),  Klf4 (C1-C4), Nanog (D1-D4) and Sox2 (E1-E4).  
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3.2.1.2.6. Electrophysiology analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20: Electrophysiology analysis for differentiated neurons. Whole-cell current clamp recordings of 
differentiated neuronal (A and B) and cardiomyocyte cells (C). Recording visualization on the oscilloscope 
in the beating area (D). A cardiomyocyte patched in the beating area (E). 
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In order to promote directed differentiation of ES-like cells into the neural and 
cardiomyocyte fate, isolated EBs from ES-like cells differentiated in the presence of RA 
and FBS respectively.  
After plating of EBs in tissue culture plates, neuronal morphology and beating areas 
were clearly observable and electrophysiological analysis of the differentiated cells was 
performed. 
We analyzed the generation of action potentials in differentiated neuronal cells (Figure 
3.20A and B). Upon a brief current pulse of 5ms, all cells (n=6) could fire an action 
potential, long current injections of 5s resulted in two types of activity.  
There were either cells that fired continuously, like cell 1 (Figure 3.20A, 2 cells out of 6 
cells recorded) or cells that would not fire, like cell 2 (Figure 3.20B, 4 cells out of 6 cells 
recorded). Interestingly, after action potential generation, the recorded cells gave rise to 
a strong hyperpolarizing current. Moreover, the resting membrane potential was very 
variable between the cells (Figure 3.20). 
In addition, the pacemaker activity was analyzed by whole-cell current clamp for 
differentiated cardiomyocyte. It was observed that in the beating regions, the cells 
performed a rhythmic action potential generation over time, with constant amplitude 
(Figure 3.20C, D and E).   
  
3.2.1.2.8. Tumor formation in SCID mouse after injection of ES-like cells 
The development of teratoma formations is one of the most important functional 
methods for the characterization of pluripotency in stem cells studies. 
In our study, the pluripotency of ES-like cells was verified by subcutaneous injections of 
about 2х106 ES-like cells to five nod SCID mice. About 4 weeks after transplantation of 
the ES-like cells, we could observe teratoma in all five nod scid recipient mice and no 
teratoma were observed in the control group (just transplanted matrigel) (Figure 3.21). 
Hematoxylin-Eosin staining for teratoma showed many highly differentiated structures of 
ectodermal, mesodermal and endodermal origin in these encapsulated tumors. All three 
germ layers from ES-like cells derived teratoma are shown (Figure 3.21). 
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Figure 3.21: Teratoma formation in SCID mouse after transplantation of ES-like cells. 
Teratoma formed after the transplantation of GPS cells into SCID mice (A). Ectormal and endodermal 
epithelium were observable, here a crosswise truncated lumina with gut epithelium and goblet cells is 
shown (B). Respiratory epithelium of endodermal origin (C). Example of an early neuronal rosette (D). 
Structures for mesodermal origin, early cartilage formation and other more unorganized connective 
tissues were observable (E). Structures of keratinizing epithelium were clearly observable (F).  
 
 
3.2.1.2.9. Chimera formation after injection of ES-like cells into blastocyst   
To answer the question whether ES-like cells are similar to ESCs contributing to embryo 
development in-vivo, we investigated chimera formation by injection of GSCs into 
mouse blastocyst. About 10–15 single ES-like cells were selected by a 
micromanipulator (Figure 22A) and injected into 3.5 day old mouse blastocysts of the 
embryo (Figure 3.22B and C). 
Injected embryos were transferred into the uterus of pseudo pregnant recipient females 
and gestated for 18 days.  The resulting pups were analyzed for chimera formation by 
coat color (Figure 3.22D). In some of the pups, coat color exhibited patches of coat 
color from the host embryo, but also patches from the respective injected ES-like cell 
clone. 
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Figure 3.22: Generation of chimeric animals. About 10–15 single ES-like were ollected cells by a 
micromanipulator. (A) Injection of ES-like cells into blastocyst (B and C), identification of chimera mice by 
coat color (D). 
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Chapter 4 Discussion 
 
4.1. In-vivo and in-vitro identification of germ cells by analysis of different germ 
cells markers 
 
4.1.1. Oct4 expression in the germ cells 
During early development, Oct4, a 352 amino acid protein, is expressed in pluripotent 
ESCs, blastomeres and in the inner cell mass of the blastocyst [141, 142]. After 
gastrulation, the Oct4 is down-regulated in trophectoderm and primitive endoderm but 
maintained in PGCs [142]. PGCs maintain the expression of Oct4 until the initiation of 
the spermatogenesis in males or oogenesis in females [142]. Our study provides 
evidence for the expression of Oct4-GFP in the seminiferous tubules of Oct4-GFP 
transgenic testis throughout life. We observed that the numbers and signal density of 
Oct4-GFP in the seminiferous tubule of the neonate mouse testis was higher than in 
adult mouse testis (~6 month old). The reduction of Oct4 expression during age may be 
related to a reduction of gonocytes and undifferentiated SSCs pool in the testis of 
neonates and older animals. On the other hand, we observed that the enhancement of 
Oct4 expression in the neonate testis is detectable not only in undifferentiated SSCs but 
also in T1-prospermatogonia. In addition, a low OCT-4 signal is also observable in 
spermatocytes (Figure 3.1A1-A4).  
 
4.1.1.1. Different isoforms of Oct4 in germ cells 
With alternative splicing and alternative translation, three mRNA isoforms of Oct4 genes 
including Oct4A, Oct4B and Oct4B1 and four protein isoforms including Oct4A, Oct4B-
190, Oct4B-265, and Oct4B-164 are present in the human cells [143, 144]. Oct4A is a 
transcription factor that confirmed the stemness and pluripotency state of ESCs [145-
148]. Oct4B is mainly localized in the cytoplasm of non-pluripotent cells which cannot 
maintain ES cell self-renewal and reduced in non-pluripotent stem cells [148]. During 
co-expression of Oct4A and Oct4B, activation of transcriptions by Oct4A was not 
repressed by Oct4B and in parallel overexpression of Oct4B was not activated by Oct4A 
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[148]. Two variants of the Oct4 gene including Oct4A and Oct4B were identified in 
mouse cells [149] . Oct4A exists only in one variant, which is the main regulator of 
pluripotent stem cells, while three isoforms of Oct4B include Oct4B-247aa, Oct4B-
190aa and Oct4B-164aa were detected in somatic cells of the mouse [149]. 
Oct4 expressed in undifferentiated SSCs is required for maintenance of SSCs during in-
vitro culture and is also important for colonization activity following cell transplantation 
[109, 150]. Although the expression of the Oct4A and B pattern have been shown in 
human testis [151], there is no evidence of different variants of Oct4 in the mouse testis.   
In our study, we used the Oct4 antibody from Abcam (ab19857) and Santa Cruz (SC-
8628) to identify germ cells and pluripotent stem cells. For antibody generation,Santa 
Cruz used peptide from N-terminal and Abcam again C-terminal of Oct4 protein. 
Warthemann et al demonstrated that Oct4 from Abcam (ab19857) is common to both 
Oct4A and Oct4B, while the Santa Cruz antibody (Sc-5279) is directed against Oct4A 
[152].   
In the testis section, we observed expression of the Oct4 gene in the seminiferous 
tubule of mouse testis (with the Abcam, but not from Santa Cruz antibody). We detected 
that the level of Oct4 expression in the SSCs population, was higher than in 
differentiated spermatogonial cells.  
This result confirms down-regulation of Oct4 expression during spermatogenesis. This 
could be related to the production of different differentiation factors produced by sertoli 
cells in the two different compartments surrounded and separated by these cells, the 
stem cell and the differentiation compartment [153].  
With immunocytochemistry, we did not detect Oct4 expression using the Santa Cruz 
antibody in the testis section or in-vitro in Type I and Type II cells. However, we 
detected Oct4 in generated ES-like and mESC cells using this antibody.  
Oct4 mRNA was observable in ES-like cells, Type I, Type II cells and also in low levels 
in somatic feeders. In the primary culture of isolated SSCs from Oct4-GFP transgenic 
mice Oct4 was expressed in low level in the Type I cells but not in Type II cells. 
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4.1.2. PLZF 
The transcription factor PLZF has an essential role in the maintenance and self-renewal 
of the SSC pool in the testis [119]. The functional importance of PLZF was shown in 
Zfp145–/– mice (Zfp145-null mice) were spermatogenesis is lost. 
In addition, PLZF is expressed during embryogenesis and regulates limb and axial 
skeletal patterning [154]. PLZF has genetic interaction with Gli3 (GLI-Kruppel family 
member 3) and Hox5 genes during limb development [155, 156]. 
In the testis section, just a few cells in the basement membrane of seminiferous tubule 
expressed PLZF. It has been demonstrated that PLZF expression is restricted to As, 
Apr and Aal SSCs [157].  
Figure 4.1: Schematic illustrations for expression of different germ cells markers in the seminiferous 
tubule 
 
PLZF is co-expressed with Oct4 in undifferentiated mouse spermatogonial cells [157]. 
Similarly, Filipponi et al. observed both PLZF+-Oct4+ and PLZF+-Oct4- cells in testicular 
germ cells. They suggested that PLZF+-Oct4+ cells are As spermatogonia and PLZF+-
Oct4- cells are Ap spermatogonia [109]. In our experiments, about 40 percent of cells in 
the cross section of 6 week-old mouse testis were PLZF+-Oct4- . Unlike Oct4, we 
confirmed that localization of PLZF was restricted to the basement membrane of 
seminiferous tubules. Until now, the mechanisms of down regulation of PLZF during 
spermatogenesis were not fully understood.  
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We observed that all PLZF and Oct4 positive cells showed low expression for DAZL and 
VASA protein (Figure 4.1).  
In germ cells, PLZF represses both kit expression and expression of a reporter gene 
which is under the control of the kit promoter region [109] . 
Hobbs et al identified an antagonism between Sall4 and PLZF. They demonstrated that 
Sall4, with inhibition of PLZF, induces the expression of c-kit and promotes postnatal 
spermatogonial progenitor cells (SPCs) [105]. 
In prostate cancer cell lines, it has been demonstrated that PTEN suppresses and 
phosphoinositide 3-kinase (PI3K) inhibitor treatment increases PLZF expression [158].  
 
4.1.3. VASA and DAZL 
In the adult testis, VASA protein was expressed in the cytoplasm of spermatocytes and 
round spermatids [159]. It is essential for the proliferation and differentiation of male 
germ cells during development [160]. 
Male mouse homozygotes for VASA homolog gene (Mvh) produce no sperm or 
premeiotic germ cells [160]. 
Similarly DAZL is a cytoplasmic protein which is expressed in germ cells. In adult rat 
testis, a weak DAZL signal was detected in the spermatogonia, intermediate  and also 
in primary spermatocytes [161]. Highest intensity for DAZL protein expression was 
detectable between stages IV and VIII during the spermatogenic cycle and first meiotic 
division [161].  
In the seminiferous tubule of the adult mouse testis, we observed DAZL protein only in 
cells located above the basement membrane and a decrease of VASA protein 
expression during differentiation to sperm. These results confirmed that VASA and 
DAZL proteins, although they were not expressed in undifferentiated SSCs (they were 
negative in PLZF and Oct4 positive cells), were expressed in progenitor SSCs and 
down-regulate during differentiation into sperms (Figure 4.1).  
In-vitro culture of Types I and II cells, we observed that Type I cells clearly expressed 
VASA and DAZL but Type II cells had a very low expression signal for VASA, but were 
completely negative for DAZL. We also confirmed that VASA and DAZL positive cells in 
Type I cells were completely negative for VIMENTIN and clearly expressed several 
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germ cells markers such as PLZF. These results might confirm that the gene expression 
pattern in SSCs, which exist in the testis niche in-vivo, might be different in in-vitro. For 
example, unlike in-vivo SSCs in the testis, VASA and DAZL positive cells during in-vitro 
culture were positive for PLZF and Oct4 proteins.    
 
4.1.4. Klf4 and N-Myc 
In the cross sections of mouse testis, we found cytoplasmic expression for Klf4 by IMH. 
Klf4 expression started in a cell layer above the basement membrane compartment until 
differentiated cells of testis that are responsible for spermatogenesis while N-Myc 
proteins were expressed only in the middle part of tubular lumen. 
In the mouse testis section, we observed that Oct4+, PLZF+, Sox9+ and interstitial cells 
were negative for Klf4 and N-Myc proteins.  
During in-vitro culture, we confirmed that Type I cells were negative for Klf4 but were 
positive for N-Myc, while Type II cells expressed both Klf4 and N-Myc protein.  
Undifferentiated spermatogonial cells in the testis section were negative for Klf4 and N-
Myc, while differentiated cells in the testis were positive for both markers. Similar to 
testis sections, Type II cells were positive for both markers while Type I cells were 
negative for Klf4 but positive for N-Myc protein. In testis sections, N-Myc positive cells 
were negative for DAZL and VASA, while this gene expression pattern was same for 
Type II cells but not for Type I cells (N-Myc expression) during in-vitro culture.  
Although Type I cells were negative for Klf4 but we observed mRNAs expression similar 
to mESCs. This result might confirm that in Type I cells, mRNA for Klf4 were abolished 
for protein translation by an unknown mechanism.  
Klf4 has also been shown to be an important transcription factor for the regulation of 
pluripotent cells [136]. Klf4 accompanied by the genes Oct4, Sox2 and C-Myc, are the 
main transcription factors for a generation of iPSCs from somatic cells [135, 136]. Beher 
et al showed that Klf4 is expressed in high levels in the nucleus and cytoplasm of round 
spermatids, postmeiotic germ cells and leydig cells, but not in sertoli cells [162], both in 
the human and mouse testis. These results suggested the importance of Klf4 during 
spermatogenesis. Further analysis has shown that deletion of Klf4 in germ cells did not 
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prevent complete spermatogenesis and mutant mice had normal testes and fertility 
[163]. 
Klf4 is known to be involved for transition of a normal fetal germ cell to a germ cell 
tumor. It has been reported that mRNA expression for Klf4 gene in seminoma testis was 
higher than in normal testis [164]. 
Depending on the activation of different signalling pathways, Klf4 can act as an 
oncogene (inactivation of the cyclin D1 proto-oncogene and the cyclin-dependent 
kinase inhibitor p21) or tumor-suppressor (directly suppress the expression of p53 
promoter) [165, 166]. 
Myc proto-oncogene protein has been demonstrated to be involved in many cellular 
functions and regulations such as cell proliferation, apoptosis, metabolism activity and 
DNA synthesis [167, 168]. Myc activity was essential for ESC maintenance by 
controlling the LIF/STAT3 self-renewal pathway [169]. Similarly, C-Myc and N-Myc 
proteins control cellular functions such as proliferation, differentiation and survival in 
HSC (hematopoietic stem cell) [170]. In stem cells and neuroblastoma tumor, N-Myc 
protein can regulate the expression of a number of pluripotency genes such as LIF, 
Klf2, Klf4 and LIN28b [171].  N-Myc has been shown to be able to block differentiation in 
medulloblastoma cells and promote progression to tumors [172]. 
There is little evidence concerning N-Myc expression for spermatogenesis and its 
signalling pathway in the SSCs. Braydich-Stolle et al showed that Src kinase with 
activation of the PI3K/Akt signalling pathway could up-regulate N-Myc expression in 
SSCs [173]. In neural stem cells, N-Myc protein can be replaced by insulin-like growth 
factor signalling (IGF) pathways in a mouse model of sonic hedgehog-induced 
medulloblastoma [174].  
 
4.1.5. Sox9 and VIMENTIN 
Sertoli cells produce different cytokines and thereby can regulate SSCs functions in the 
male gonad. In testis sections, Sox9 expression was limited to the Sertoli cells and its 
use in combination with VIMENTIN is a highly specific marker for identification of sertoli 
cells in testis [175]. 
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In the present study, we observed nuclear expression of Sox9 protein only in cells in 
connection to basement membrane of seminiferous tubules that were negative for Oct4, 
PLZF, VASA, DAZL, N-Myc and Klf4, but which were positive for VIMENTIN.  
The Sox9 transcription factor is a member of the Sox gene family, similar to Sox8 and 
Sox10, and plays a critical role during embryogenesis  for cellular differentiation of 
various tissues such as sertoli cells of the testis [176], neural crest cells [177, 178] and 
chondrocyte differentiation [179, 180].  
The Sox9 gene also plays a crucial role for vertebrate sex determination which are 
regulated by SRY gene [181]. Fgf9 and Wnt4 proteins are expressed in the gonads of 
both sexes as antagonistic signals for sex determination [182]. 
During early testis development, FGF9 is important for the proliferation of a population 
of cells which give rise to sertoli progenitors and for localization of FGF receptor 
(FGFR2) in the nucleolus of early differentiated sertoli cells [183]. These events overlap 
with Sry expression and the nucleus localization of Sox9 during the earliest stage of sex 
determination (about 11.0 and 11.2 dpc).  
Experiments showed that Sox9 has been used for identification of sertoli cells in 
transplantation studies [175]. In the testis section, sertoli cells contain intermediate 
filaments (IFs) which expand throughout the whole cytoplasm [184]. IFs were also found 
in interstitial cells, such as peritubular-myoid cells and leydig cells [185, 186].  
It has been shown that the distribution of VIMENTIN filaments in sertoli cells is related 
to the cycle of seminiferous epithelium and also depends on the location of the 
spermatid heads [187]. 
Busulphan treatment modified expansion of VIMENTIN filaments in the sertoli cells 
which alter structural integrity of the seminiferous epithelium [188]. Alterations in the 
distribution of VIMENTIN filaments in the sertoli cells are related to apoptosis of germ 
cells [189]. VIMENTIN is also expressed during the maturation phase of spermatids of 
germ cells where the distribution of IFs are organized differently within sertoli cells [190]. 
 In our experiment, we also observed low expression of VIMENTIN in the differentiated 
SSCs of testis and that unlike Type I cells, Type II cells during in-vitro culture clearly 
expressed the VIMENTIN marker.  
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Although Type II cells were positive for VIMENTIN, in comparison with Sertoli cells, they 
had a different morphology, low expression of Sox9 and only partial expression of germ 
cells markers. In addition to these results, Type II cells expressed N-Myc and Klf-4, 
which are negative in sertoli cells.  
 
4.2. Identification, culture and expansion of SSCs  
 
4.2.1. Expression of different surface markers 
While some surface markers were used for the identification of SSCs, no highly specific 
markers for the identification and isolation of SSCs have been identified until now.  
In our experiments we observed a high expression of surface markers CD9, CD29 and 
CD49, E-cadherin and GFRa1 in the Type I and II cells, while low expression of GFRa1 
and E-Cadherin was observed in the ES-like cells. 
Analysis confirmed that E-cadherin cell adhesion protein is a highly speciﬁc surface 
marker which can be used for enrichment of mouse SSCs [191, 192] although it might 
be expressed only by a small sub-population of undifferentiated SSCs [193].  
E-cadherin is critical for the maintenance of pluripotency of mESCs and inhibition of E-
cadherin promotes differentiation to epithelial cells [194, 195]. E-cadherin-mediated cell-
cell contact is important during reprogramming and for efficiency of iPS cells [196]. E-
cadherin can be replaced with exogenous Oct4 during somatic cell reprogramming [194] 
(For more about the importance of E-cadherin effect, see review [197]). 
Similarly, surface marker THY1 (CD90) has been shown to be a conserved marker for 
undifferentiated SSCs in bulls [61, 198]. Some of the integrin subunits such as alpha 6 
(CD49) and beta1(CD29) are expressed on the surface of SSCs and can also be used 
for the enrichment of SSCs [42, 199] but they are not specific for SSCs and can also be 
expressed by somatic cells in the testis [200].  
Also the CD9 surface molecule has been used for enrichment of SSCs in the testis of 
mice and rats [201]. After xenotransplantation of enriched CD9-positive cells from 
human testis, colonization was higher in comparison with unsorted human testis cells 
[202].  
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It has been shown that the activation of LIF/STAT3 pathway induces the expression of 
CD9, which is important for maintenance of undifferentiated ESC and in addition of anti-
CD9 antibodies reduced colony formation and cell viability [203].  
GFRa1 receptor is another important cell surface marker which is expressed in 
undifferentiated SSCs in rodents and used as a protein for sorting of undifferentiated 
SSCs [107, 204]. As we mentioned before (chapter 1), GFRa1 receptor by activation of 
the Ret signalling pathway stimulates self-renewal and proliferation of SSCs [205].   
The C-kit proto-oncogene surface molecule is expressed in differentiated SSCs [206].  It 
has been shown that the C-Kit protein is expressed in low level in the undifferentiated 
Type A SSCs while level of C-kit expression is enhanced when undifferentiated 
spermatogonia are shifted into A1 cells [206]. For example, the expression of the 
melanoma cell adhesion molecule (MCAM) was recently used as another factor for 
enrichment of SSCs [45]. 
 
4.2.2. Morphological selection 
As we mentioned above, diverse gene expression patterns are present in the different 
testis cells. For this reason, scientists used different approaches for the isolation of 
SSCs by extracellular matrixes, FACS, MACS, transgenic animals or morphology based 
selection. Here, we describe for the first time the characterization of two different types 
of testis cell population (we named them Type I and Type II cells) during in-vitro culture. 
These two types of cells were different in isolation, morphology, culture conditions and 
gene expression. We believe that Type I cells might be undifferentiated but Type II cells 
seem to be differentiated SSCs in evaluation and comparison with in-vivo testicular 
cells.     
In the present study, cell separation was achieved by morphological based selection to 
purify/enrich two types of cells from the somatic cells of the mouse testis. The two types 
of cells were easily distinguishable from each other and from testicular somatic cells 
(Figures 3.4 and 3.5).  
We observed the growing of Type I cells that ceased after long term in primary culture 
and needed MEFs feeder for expansion while Type II cells could grow in primary culture 
with somatic feeders.  
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Differences in growing conditions of the two cell populations in primary somatic cells 
might be related to:  
1- Existence of different somatic cell populations, 2- Difference in production (or 
concentration) of different cytokines which are produced by the different primary 
somatic cells. We also observed that long term culture and expansion of Type II cells 
only occurred on SNL feeders but not on MEF feeder.  
As we mentioned before, SNL feeders are one type of MEF feeder which produce LIF in 
the culture media and are suitable for human iPSC culture [207]. There are some 
reports that show that LIF individually does not have any effect on SSCs during short 
term culture, but in combination with other growth factors could support proliferation of 
SSCs [208-211] (see introduction part). It has been shown in human amniotic epithelial 
cells that a high expression of LIF maintains mouse SSCs in an undifferentiated state 
[212]. In monkey ESCs, LIF enhances germ cell differentiation (increased high level of 
germ cell marker expression) [213].  
The question why Type II cells grow on primary TSCs and SNL feeder but Type I cells 
could emerge on primary TSC feeder and be expanded on MEF feeder, could be 
related to different cytokines which are secreted from the different primary testicular 
cells such as sertoli cells, leydig cells and myoid cells.  
Because we used a low concentration of serum in GS culture media, the kinetic growth 
of TSCs was not fast. Especially in old mice the kinetic grow on TSCs was much slower 
than those from neonate SSCs. Therefore the condition was ideal for Type II cells 
(instead of high growing of TSCs). Unlike with human cells, in the mouse testis, growing 
of TSCs was limited only to a few passages (about 1-2) after initiation of culture in 
mGSCs medium [65] and it was not clear which population of TSCs dominated other 
types of cells. Therefore productions of cytokines might have been different in the 
culture media.  
Because of variant molecular properties and character, Type I and II cells react 
differently to these culture conditions. The exact mechanisms were not clear yet but 
Type I and II cells require MEF and SNL feeder for more expansion. Similar with 
neonate mouse GS cells in Shinohara experiments [76], neonate and adult Type I cells 
had a low rate of growing on primary passage on MEF feeder (4-6 weeks) and higher 
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rate of growing (3-4 weeks) during further passages but this rate of growing for Type II 
cells in every passage was the same (3-4 weeks).  
 
4.3. Spermatogonia and somatic cells potential for Type I and II cells 
We performed different characterization and analysis for Type I and II cells to show 
spermatogonial potential of both Types of cells. With morphology analysis, both types of 
cells have single, pair and aligned morphology which is typical morphology for 
undifferentiated and progenitor spermatogonial cells in-vivo [34, 35]. While somatic cells 
and sertoli cells have adherent morphology [214] , Types I and II cells cultured as 
colony formation.  
Another characteristic for Types I and II cells in comparison with somatic cells was rate 
of growth. Unlike human testicular cells, growth of TSCs ceased a few weeks after 
cultivation in GSCs medium but both Types of cells had more than 1 year in cultivation 
in GSCs medium.  
Electron microscopic analysis showed big nucleolus and small cytoplasm for Type I 
cells. High ratio of nucleolus to cytoplasm is an important property of undifferentiated 
SSCs in testis [215]. In contrast we observed a low ratio of nucleolus to cytoplasm in 
Type II cells [216].   
 As we mentioned, mRNAs and protein analysis confirmed Type I cells clearly, while 
Type II cells partially expressed typical germ cells markers.    
 
 
 
Type I Type II 
sertoli cells 
(in-vivo) 
Somatic 
cells 
Cell 
morphology 
single and aligned 
chains 
morphology 
single and aligned 
chains 
morphology 
adherent 
monolayer 
culture 
adherent 
monolay
er culture 
Electron 
microscopic 
high 
nucleus/cytoplasm 
ratio 
low 
nucleus/cytoplasm 
ratio 
NT NT 
Limitation for Unlimited (more unlimited (more NT About 2 
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growing than 1year) than 10 months) passage 
Transplantation NT sperm NT NT 
Germ cells 
markers 
expression 
express typical 
germ cells 
markers 
partially express 
germ cells 
markers 
negative negative 
Sox9 
expression 
low low positive negative 
VIMENTIN negative positive positive positive 
Klf4 expression negative positive negative negative 
Pluripotency 
potential 
positive negative NT negative 
 
Table 4.1: Comparison of Type I, II, sertoli and somatic cells 
 
Since Type II cells were partially positive for germ cell markers and also expressed 
some TSC cells markers such as VIMENTIN, we considered the functional property of 
Type II-GFP cells by transplantation to an infertile mouse model. We observed 
localization of Type II cells in the basal compartment of seminiferous tubule of infertile 
mice and GFP-sperms. These results showed that both Types of cells might be SSCs 
but not somatic cells with different lineage in testis.  
 
4.4. Application of germ line stem cells 
 
4.4.1. Pluripotency of germ cells 
Although SSCs expressed some genes of pluripotency, due to the heterogeneity of 
SSCs in the testis, it is not clear from which type or population of testicular cells, ES-like 
cells were generated from. In our experiment, we generated two different cell 
populations from testis cells and reprogramming only occurred in the Type I cell 
population and not in the Type II cells.  
In the pluripotent stem cells, the expressions of core transcriptional genes include Sox2, 
Nanog and Oct4.  
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These transcriptional factors control the expression of different lineage-specific genes 
and sustain maintenance of pluripotent cells from differentiation [147].   
We showed expression of pluripotency markers (although they were not at the same 
level with mESCs) which were expressed in Types I and II cells. We confirmed that both 
cell types showed low expression of Nanog and Sox2. We also observed that Type I 
cells were negative for Klf4. 
It has been shown that germ cells expressed all of the different Yamanaka markers at 
the mRNA level, while mRNA for Sox2 was not translated into a protein [217]. It has 
been documented that blastocysts with a deficiency in Sox2 are unable to shape a 
pluripotent inner cell mass (ICM) with loss of pluripotency state [218]. The Nanog 
transcription factor maintains self-renewal in mESCs during independent mechanism of 
LIF/STAT3 signaling pathway [219]. In mESC deletion of Nanog causes loss 
of pluripotency state and differentiation into extraembryonic endoderm cell lineage 
[219].  
During the initiation of culture, Type I cells expressed Oct4 mRNA but down-regulated 
this gene completely during long term culture until they shifted to ES-like cells which 
restored mRNA expression of Oct4 in same level as mESCs. In the pluripotent ESC, a 
special level of Oct4 mRNA expression was essential for the undifferentiated state of 
pluripotency [146]. With the overexpression of Oct4 mRNA until about two-fold caused 
loss of pluripotency state and differentiation into primitive endodermal cells and 
mesodermal cells whereas 50% repression of Oct4 supported dedifferentiation into 
trophectoderm cells [146]. It has been shown that Oct4 suppresses neural ectodermal 
differentiation and promotes mesododermal differentiation while Sox2 transcription 
factor inhibits mesododermal differentiation and enhances neural ectodermal 
differentiation [220]. 
The transcription factor Klf4 is able to cooperate with both Oct3/4 and Sox2 by 
activating a number of genes, including Klf4 itself and Lefty1. In contrast, over-
expression of Klf4 inhibits differentiation of ESCs [221].  
LIN28 was expressed in Type I cells at the same level as mESCs but was negative in 
Type II cells. LIN28 is a specific marker which is expressed in undifferentiated mouse 
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SSCs [222] but recent reports confirmed that LIN28 might not be present in adult human 
testes while a high expression was observed in human testicular germ cell tumors [223].  
The reprogramming mechanism and the establishment of ES-like cells from SSCs are 
currently not completely understood. However, it is apparent that the age of animals, the 
mouse strain, culture conditions with growth factors, cell density of SSCs during culture, 
the time period after initiation of culture and the length of culture and typical population 
of testis cells all affect the reprogramming process [51, 52, 57, 137, 138]. In addition, 
some controversial challenges exist for pluripotency and multipotency of ES-like cells 
(especially in ES-like cells which generated from human testis) [224-226].  
We demonstrated that conversion of SSCs to ES-like cells is a rare event which occurs 
spontaneously only between about 40-125 days after initiation of culture and not 
thereafter. As we mentioned in Table 4.2, ES-like cells might have a similar potential for 
teratoma formation and making chimera animal as mESCs.  
Shinohara et al generated ES-like cells about 4-7 weeks after initiation of culture in the 
neonate mouse SSCs, but the origin of ES-like cells was not clear. In order to answer 
this question Guan et al used Stra8GFP+ [57], while Seandel et al used GPR125GFP+ 
[52] reporter mice for generation of ES-like cells. The established cell lines by this 
groups were not grown clonally (initial germ cell population grown from a single cell) and 
ideal ES morphology (transitional morphophology for Seandel et al.). Ko et al showed 
that induction of pluripotency in Oct4 GFP transgenic mice was related to a special 
number of SSCs (1000-4000) and length of culture (2-4 week) but this process did not 
occur in our experiments for Type I and II cells in all experiments conducted. 
    
Age 
Enrichment 
of cells 
Culture 
medium 
Characterization 
ES-like 
generation 
Rate 
Refer
ence
s 
Neonate 
mouse 
Supernatants 
in primary 
culture after 1 
day 
Stem pro 
Medium with 
GDNF, 
FGF,EGF,LIF, 
2%FCS 
Gene expression, 
teratoma, chimera, 
EBs formation and in-
vitro differentiation to 
embryonic lineage 
Spontaneo
usly 4-7 
week after 
initiation of 
culture 
19% [137] 
4-6 Week Stra8-GFP Different Gene expression, Spontaneo 27% [57] 
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mouse mouse 
model, 
condition with 
DMEM,15% 
FCS, GDNF, 
LIF,MEEF 
teratoma, EBs 
formation,  in-vitro 
and in-vivo 
differentiation to 
embryonic lineage 
usly 4-7 
days 
3week to 
8 month 
mouse 
Isolation of 
GPR125 cells 
and culture 
on TSCs 
Feeder 
Stem pro 
Medium with 
GDNF, 
FGF,EGF,LIF, 
2%FCS 
Chimera and 
teratoma formation, 
in-vitro and in-vivo 
differentiation to 
embryonic lineage 
after 2 
week, 
transitonal 
colony 
- 
[52] 
 
5-8 week 
Low 
expression of 
Oct4 positive 
cells 
Stem pro 
Medium with 
GDNF, 
FGF,EGF,LIF, 
2%FCS 
Gene expression, 
chimera and 
teratoma formation, 
in-vitro and in-vivo 
differentiation to 
embryonic lineage 
After 2 
week in 
4000 cells 
per each 
well 
- [51] 
Neonate 
mouse 
Testicular 
culture on 
gelatine 
DMEM,GDNF, 
FGF,EGF,LIF, 
2%FCS 
Gene expression, 
chimera , EBs 
formation, in-vivo 
differentiation to 
embryonic lineage 
Using small 
molecule, 
After 2 
week, 
- [138] 
Neonate 
and adult 
Morphology 
selection 
Stem pro 
Medium with 
GDNF, 
FGF,EGF,LIF, 
2%FCS 
Gene expression, 
EBs formation, in-
vivo differentiation to 
embryonic lineage 
40-110 day 
after 
initiation of 
culture 
33% 
Azizi,  
in the 
prep
aratio
n 
 
Table 4.2: Generation of ES-like cells from testis under different conditions 
 
In the pluripotent stem cells, two phases of naive and prime pluripotency states have 
been suggested by Nichols et al [227].  
Naive pluripotent cells, such as early epiblast stem cells or ESCs, could make teratoma 
formation and chimera formation, whereas prime pluripotent stem cells similar to late 
epiblast cells or post-implantation epiblast cells could create teratoma formation but 
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could rarely make any chimeric animals [227]. ES-like cells which were generated from 
Seandel and Guan et al groups might have been prime pluripotent cells. 
 
4.4.2. Infertility applications 
Infertility treatment is another important aim for application of germline stem cells. 
Infertility in primates and non-primates might be related to genetic deficiencies, 
therapeutic reasons or toxic agents from the environment [228].  
In patients undergo chemotherapy or radiotherapy treatment especially in young 
prepubertal and adolescent cancer patients,  preservation of fertility by restoring SSCs 
and transplanting them after treatment is a reasonable approach [229]. Similarly, 
hormone applications have been shown for preservation and restoration of fertility after 
cancer treatment [230].  
Because SSCs do not really possess specific marker for their identification, 
transplantation of labelled candidate cells into infertile models and tracking of 
spermatogenesis is a very powerful technique for the identification of SSCs. 
In our experiments, we observed that Type II cells partially expressed germ cells 
markers and therefore we assessed the functional properties of Type II-GFP cells by 
transplantation into an infertile mouse model. About one month after transplantation, we 
observed localization of Type II cells in the basal compartment of the seminiferous 
tubule of an infertile mouse, also in addition to GFP positive spermatids. About three 
months after transplantation, we observed GFP- positive sperms in the epididymis. 
In conclusion, we generated two different cell populations under germ stem cell 
conditions in-vitro. These two SSC populations have different potential for clinical 
treatments. If Type II cells actually display differentiation potential for SSCs, they would 
be one step further than undifferentiated SSCs and therefore in-vitro differentiation to 
sperm might be much easier than starting from undifferentiated SSCs.  
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Appendix 
Consumable items include materials, enzyme, chemical, solutions, growth factors, antibody, 
primers used for PCR, concentration of components in the associated solutions and mediums 
have been described with more detail in the appendix  
 
Table 1: Materials for cell culture 
Materials  Company Materials  Company 
T25 and T75 Cell culture 
flaske 
Greiner Cell Culture Dishes Greiner 
Cell culture plate: 6-well, 
12-well, 24-well, 
Greiner Microcentrifuge tube Plastibrand 
Falcon tubes: 15 and 50ml Greiner Serological Pipets Greiner 
Bottletop Filters Millipore  Cell Culture Scrapers Greiner 
Freezing cryovial Nunc 
Thermo 
Cover glass Deckglaser 
Millex Syringe BD Cell strainer: 40µm and 70 µm BD 
Syringe BD Bacterial dishes for 
suspension culture 
Greiner 
Isopropanol freezing 
container 
Nunc 
Thermo 
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Table 2: Enzymes and chemicals for cell culture 
Title Company Title Company 
Collagenase IV Sigma-Aldrich Dispase Sigma-Aldrich 
DNAse Sigma-Aldrich Trypsin-EDTA Gibco 
Mitomycin C Roche Gelatine Sigma-Aldrich 
Matrigel    
 
Table 3: Solutions for cell culture 
Solutions Company Solutions Company 
StemPro-34 medium Invitrogen DMEM/F12 PAA 
HBSS buffer with 
Ca++ and Mg++ 
PAA DMEM high-glucose Invitrogen 
KO-DMEM Invitrogen PBS PAA 
Penicillin/Streptomycin  PAA β-mercaptoethanol  Invitrogen 
Trypan blue Invitrogen DMSO AppliChem 
poly-L-ornithine Sigma-Aldrich 
 
Table 4: Growth factors for cell culture 
Growth factors Company Growth factors Company 
FBS and ES-cell 
qualified FBS 
Invitrogen StemPro-34 
supplement 
Invitrogen 
D+ glucose Sigma-Aldrich N2-supplement Invitrogen 
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L-glutamine, PAA Progesterone  Sigma-Aldrich 
Bovine serum 
albumin  
Sigma-Aldrich MEM vitamins  PAA 
Non-essential 
amino acids  
PAA FGF  Sigma-Aldrich 
Estradiol  Sigma-Aldrich Pyruvic acid  Sigma-Aldrich 
EGF Sigma-Aldrich LIF  Millipore 
DL-lactic acid Sigma-Aldrich Ascorbic acid  Sigma-Aldrich 
BSA Invitrogen L-glutamine  PAA 
RA Sigma-Aldrich   
 
Table 5: Consumable items used for Histology, Electrophysiology and EM 
Titles Company Titles Company 
DNAse Promega PIPES Serva 
Electrophoresis 
Paraformaldehyde Applichem Glutaraldehyde Serva 
Electrophoresis 
Uranylacetat 
 
Serva 
Electrophoresis 
Potassium 
hexacyanoferrate 
Serva 
Electrophoresis 
Sodium maleate 
buffer 
Serva 
Electrophoresis 
OsO4 Serva 
Electrophoresis 
Epon-embedded Serva 
Electrophoresis 
Paraplast Plus Langenbrinck 
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PBS Invitrogen Triton Merck  Millipore 
DAPI Sigma BSA Sigma 
Tissue Tek Sakura Superfrost Plus glass 
slides 
Langenbrinck 
Xylene VWR Chemicals Sodium Citrate Buffer Riedel-de Häen 
EDTA Merck  Millipore 
 
Table 6: Antibody used for staining 
Antibody Species Company Cat. number Concentra
tion 
c-Myc ms mono IgG1 Invitrogen 460603 1:500 
CD 29-APC mouse MACS 130-096-356 1:11 
CD 49f -APC rat IgG 2a R&D Systems FAB13501A 10 µl (0,1 
µg) 
CD 9-APC rat IgG 2a R&D Systems FAB 5218A 10 µl (0,1 
µg) 
CD 117-APC mouse MACS 130-091-729 1:11 
DAZL  ms  mono IgG1 AbD Serotec MCA 2336 1:100 
E-Cadherin-
APC 
rat IgG 2a R&D Sytems FAB7481A 10 µl  (0,1 
µg) 
GFAP rab poly Dako Z0334 1:400   
GFAP ms mono Chemicon MAB 3402 1:400 
Cop-GFP rab poly Evrogen AB 501 1:15.000 
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GFP (4B10) ms mono Cell Signalling 2955 1:100 
GFR α1 rab poly Sigma SAB 4501166 1:50 
Klf4 rab poly Cell Signaling 4038 1:100  
MAP 2 ms mono Sigma M 1406 1:200 
MAP 2  ms mono Sigma G 3893 1:200 
Nanog  rab  poly Abcam ab80892 1: 100  
Nanog  rab poly Abcam ab 21624 1:100-400 
Nestin  ms mono Abcam ab 22 035 1: 500  
Nestin ms mono BD  556 309 1: 100 
Neu N  mouse mono Chemicon MAB 377 1: 100 
N-Myc  mouse mono Abcam ab 16898 1: 50 
Oct 4  rab  poly   Abcam ab19857 1:200 
Oct3/4 (C-10) ms mono  Santa Cruz  SC -5279 1:100  
PLZF (2A9)  ms mono Calbiochem OP128 1:100 
Sox2  rab poly Abcam ab 15830 1:100  
Sox2   ms  mono Abcam ab 75485 1:100  
Sox9 rab poly Linaris PAK0058 1:50 
ß-Tubulin III   ms mono Covance MMS-435-P 1:500 
ß-Tubulin III  ms mono Sigma T8660 1:400 
VASA (DDX4) rab Abcam ab 13840 1:100 
VASA goat poly R&D System AF 2030 1:100 
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VIMENTIN  mouse mono IgM Sigma Aldrich V2258 1:100 
VIMENTIN  mouse mono Dako M 0725 1:100 
 
Table 7: Materials and solutions used for RNA analysis 
Items  Company Items  Company 
TE buffer Prepared in the Lab M-MLV Reverse 
Transcriptase kit 
(Promega, Germany) 
Direct 2× Reaction 
Mix  
Invitrogen RT/Taq Superscript 
III  
Invitrogen 
dNTP mix Promega Ethidium bromide Roth 
MgCl2 Invitrogen 1x AmpliTaq 360 
DNA Polymerase 
Applied Biosystems 
Peq GOLD 
TriFast reagent 
Peqlab, Erlangen, 
Germany 
RT-PCR primer Sigma 
qRTPCR primer Applied Biosystems 
 
Table 8: Primers used for PCR 
Name Sequence Product 
size 
Annealing 
TM (°C) 
Brachyury  
 
F: GCTGTGACTGCCTACCAGAATG 
R: GAGAGAGAGCGAGCCTCCAAAC 
231 58  
Gapdh  
 
F:GCAGTGGCAAAGTGGAGATT  
R: TCTCCATGGTGGTGAAGACA 
249 56  
 
Gata4  
 
F:CTGTCATCTCACTATGGGCA  
R: CCAAGTCCGAGCAGGAATTT 
257 56  
 
α- F:CCCACCCTTCCAGTTTCC  150 59  
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Feteoprotein   
 
R: TCGTACTGAGCAGCCAAGG  
SM actin   
 
F:ACTACTGCCGAGCGTGAGATT  
R: GTAGACAGCGAAGCCAAGATG 
449 59  
 
Islet1  
 
F:ACGTCTGATTTCCCTGTGTGTTGG  
R: TCGATGTGGTACACCTTAGAGCGG 
275 63  
 
Keratin18   
 
F:TTGTCACCACCAAGTCTGCC  
R: TTTGTGCCAGCTCTGACTCC 
213 63  
 
Myf 5   
 
F:GGAGATCCTCAGGAATGCCATCCC  
R:TGCTGTTCTTTCGGGACCAGACAGG 
178 67  
 
 
Table 9: List of TaqMan gene expression assays for multiplex qRTPCR 
Gene Gene name Specie
s 
Assay ID 
DAZL deleted in azoospermia-like mouse Mm00515630_m1 
Ddx4 or 
VASA 
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 mouse Mm00802445_m1 
Ret Ret proto-oncogene mouse Mm00436304_m1 
Epcam epithelial cell adhesion molecule mouse Mm00493214_m1 
Kit kit oncogene mouse Mm00445212_m1 
Scp1 synaptonemal complex protein 1 mouse Mm01297993_m1 
Tert telomerase reverse transcriptase mouse Mm01352136_m1 
Bcl6b B cell CLL/lymphoma 6, member B mouse Mm00455914_m1 
Etv5 ets variant gene 5 mouse Mm00465816_m1 
Lhx1 LIM homeobox protein 1 mouse Mm00521776_m1 
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Table 10: Components in the digestion solution of testis  
Name Concentration Name Concentration 
Collagenase IV 0.5 mg/ml Dispase 0.5 mg/ml 
DNAse 0.5mg/ml HBSS buffer Up to volum 
 
ZBTB1
6 or 
PLZF 
zinc finger and BTB domain containing 16 mouse Mm01176868_m1 
Taf4b TATA box binding protein (TBP)-associated 
factor 
mouse Mm01254136_m1 
Stra8 stimulated by retinoic acid gene 8 mouse Mm01165142_m1 
IHH Indian hedgehog mouse Mm00439613_m1 
Nanog Nanog homeobox mouse Mm02384862_g1 
Lin28a lin-28 homolog A (C. elegans) mouse Mm00524077_m1 
TDGF1 teratocarcinoma-derived growth factor 1 mouse Mm00783944_g1 
Dppa5 developmental pluripotency associated 5 mouse Mm01171664_g1 
Nodal nodal mouse Mm00443040_m1 
Gdf3 growth differentiation factor 3 mouse Mm00433563_m1 
Pou5f1 
or Oct4 
POU domain, class 5, transcription factor 1 mouse Mm03053917_g1 
Sox2 SRY (sex determining region Y)-box 2 mouse Mm00488369_s1 
GAPDH glyceraldehyde-3-phosphate dehydrogenase mouse Mm99999915_g1 
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Table 11: mGSC medium 
Name Concentration Name Concentration 
StemPro-34 medium Up to volume D+ glucose 6 mg/ml 
N2-supplement 1% L-glutamine 1% 
Bovine serum albumin 5 µg/ml β-mercaptoethanol 0.1% 
Penicillin/streptomycin 1% Non-essential amino acids 1% 
MEM vitamins 1% Progesterone 60 ng/ml 
Estradiol 30 ng/ml Fibroblast growth factor 10 ng/ml 
Epidermal growth factor 20 ng/ml Leukemia inhibitory factor 100 U/ml 
Glial-derived 
neurotrophic factor  
8 ng/ml  Ascorbic acid 100 µg/ml 
ES-cell qualified FBS 1% DL-lactic acid 1 µl/ml 
Pyruvic acid 30 µg/ml 
 
Table 12: mESCs and ES-like medium 
Name concentration Name concentration 
KO-DMEM Up to volume MEM NEAA solution 1% 
FBS 15% L-glutamine 1% 
Pen-Strep 1% ß-mercaptoethanol 0.1% 
LIF 1000 U/ml   
 
 
107 
 
Table 13: SNL feeder medium 
Name Concentration Name Concentration 
D-MEM with 4500 
mg/L glucose 
Up to volume FBS 10% 
MEM NEAA 0.1 mM L-glutamine 2 mM 
Pen-Strep 1%   
 
Table 14: TSCs feeder medium 
Name Concentration Name Concentration 
D-MEM with 4500 
mg/L glucose 
Up to volume FBS 20% 
MEM NEAA 0.1 mM L-glutamine 2 mM 
Pen-Strep 1% bFGF 10ng 
 
Table 15: MEF feeder medium 
Name Concentration Name Concentration 
D-MEM with 4500 mg/L 
glucose (or KO-DMEM) 
Up to volume FBS 10% 
MEM NEAA 0.1 mM L-glutamine 2 mM 
Pen-Strep 1% 
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Table 16: Components in the freezing media 
Name Concentration Name Concentration 
TSCs medium 70% FBS 20% 
DMSO 10% 
 
Table 17: Components in the fixative solution for EM 
Fixative solution for EM Concentration Name Concentration 
Paraformaldehyde 3 % PIPES  0.1 M 
Glutaraldehyde 3% 
 
Table 18: Components in the post fixative solution for EM 
Post-Fixative solution for 
EM 
Concentration Name Concentration 
OsO4 1% Potassium 
hexacyanoferrate 
1.5% 
 
Table 19: Components in the washing buffer for EM 
Washing buffer for EM 
in (pH 6.0) 
Concentration Name Concentration 
Uranylacetat buffer 1 % Sodium maleate 0.2 M 
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Table 20.Blocking buffer for EM: 
Blocking buffer for EM Concentration 
Uranyl acetate 1% 
 
Table 21: Staining solution in the Flow cytometry 
solution  Concentration solution  Concentration 
FBS 3%  PBS 97% 
 
Table 22: Permeabilization solution for immunocytochemistry 
solution Concentration solution Concentration 
Triton 0.1 % PBS 99.9 % 
 
Table 23: Blocking solution for immunocytochemistry 
solution Concentration solution Concentration 
BSA 1 % PBS 99. % 
 
Table 24: Antigen retrieval solution for immunohistochemistry 
Solution  Concentration Solution  Concentration 
Sodium Citrate Buffer in 
pH 6 
10 mM EDTA in pH 8 1 mM 
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Table 25: Blocking solution for immunohistochemistry  
Blocking solution 
for IMH  
Concentration Blocking solution for 
IMH  
Concentration 
FCS serum 10% PBS 89.7 % 
Triton 0.3 % 
 
Table 26: Components in the PCR reaction 
PCR reaction Concentration PCR reaction Concentration 
MgCl2 1.5 mM dNTP 0.4 mM 
Forward primer 0.5 mM Revers primer 0.5 mM 
AmpliTaq 360 
PCR buffer 
1.25 U (or 1x) cDNA 1 µl 
 
Table 27: Solution for gel electrophoresis 
Solution  Concentration Solution  Concentration 
Agarose gel 2.5% TAE (Tris-acetate buffer 
EDTA) 
97.5% 
 
Table 28: Components in the lysis buffer for multiplex qRTPCR  
Lysis buffer 
solutions 
Concentration Lysis buffer 
solutions 
Concentration 
Cells Direct 2× 
Reaction Mix 
5.0 μl TE buffer 1.3 μl 
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0.2× assay pool 2.5 μl RT/Taq Superscript III 0.2 μl 
 
Table 29: Medium for EBs formation 
Components Concentration Components Concentration 
KO-DMEM desired volume MEM NEAA solution 1% 
FBS 15% L-glutamine 1% 
Pen-Strep 1% ß-mercaptoethanol 0.1% 
 
Table 30: Medium for differentiation into neuronal progenitor cells 
Components Concentration Components Concentration 
DMEM-F12 desired volume NEAA 1% 
FBS 10%, 5% and 3% L-glutamine 1% 
Pen-Strep 1% FGF  10ng/ml 
N2 1% RA 3µM 
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Table 31: Medium for maturation and development of neuronal progenitor cells 
 Components Concentration Components Concentration 
Neurobasal medium desired volume NEAA 1% 
FBS 10% and 5% L-glutamine 1% 
Pen-Strep 1% B27 2% 
B27  2% N2 1% 
RA 3µM 
 
 
Table 32: Endodermal and mesodermal differentiation medium 
Components Concentration Components Concentration 
DMEM-F12 desired volume NEAA 1% 
FBS 10% and 5% L-glutamine 1% 
Pen-Strep 1% FGF  10ng/ml 
N2 1% 
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Table 33: Intracellular Solution buffer for electrophysiology 
Intracellular Solution 
Jack Special (low 
chloride) pH=7.2 with 
KOH 
Concentration Intracellular Solution 
Jack Special (low 
chloride) pH=7.2 with 
KOH 
Concentration 
K-Gluconate 135mM Na-phosphocreatine 10mM 
HEPES 10mM KCl 4mM 
Mg-ATP 4mM Na-GTP 0.3mM 
mOsm 295 mM   
 
Table 34: Extracellular Solution buffer for electrophysiology 
Extracellular Solution 
1x aCSF (artificial 
Cerebrospinal Fluid 
Concentration Extracellular 
Solution 
1x aCSF (artificial 
Cerebrospinal Fluid 
Concentration 
NaCl 125mM KCl 2.5 mM 
NaHCO3 25mM NaH2PO4 1.25 mM 
CaCl2 2 mM MgCl2 1 mM 
Glucose 25mM 
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Abbreviation 
µL                         Microliter 
µM                        Micromolar 
Mm                      Milimolar 
RPM                     Revolutions per minute  
h                          Hour 
min                     Minute 
Ca
+2
                      Calcium ion
+2 
 
Ct                          Cycle threshold 
DNA                    Deoxyribonucleic acid 
DMSO                 Dimethyl sulfoxide 
DMEM                 DMEM Dulbecco's Modified Eagle Medium 
DNTPs               Deoxynucleotide 
e.g                        For example 
et al                      And other authors 
MgCl2                 Magnesium chloride 
mRNA                 Messenger ribonucleic acid 
FBS                      Fetal bovine serum 
FCS                      Fetal calf serum 
FGF2                   Fibroblast Growth Factor-2 
EGF                     Epidermal growth factor 
GDNF                 Glial cell line-derived neurotrophic factor  
STAT3                 Signal transducer and activator of transcription 3  
SMAD1                 SMAD family member 1  
BMP8-b               Bone morphogenetic protein 8b) 
BMP2                 Bone morphogenetic protein 2    
Cadherins            Calcium-dependent adhesion 
HOXB1                 Homeobox B1      
FGF8                  Fibroblast growth factor 8   
Dpc                      Days post coitum  
E                           Embryonic day  
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EXE                     Extraembryonic ectoderm  
SSEA1                  Stage specific embryonic antigen 1  
H3K9me2             Histone H3 dimethyl Lys9 antibody  
MAD2L2              Mitotic arrest deficient 2-like 2 
PGCs                   Primordial germ cells  
SSCs                    Spermatogonial stem cells  
FACS                   Fluorescence-activated cell sorting  
MACS                 Magnetic-activated cell sorting  
MEFs                   Mouse embryonic fibroblasts  
TSCs                    Testicular stroma cells  
EM                       Electron microscopic  
RT-PCR             Reverse transcription polymerase chain reaction  
BMP4                   Bone morphogenetic protein 4  
LIF                     leukemia inhibitory factor 
MEK                     MAP kinase  
GSK3                    Glycogen synthase kinase 3  
Tnap                  Tissue non-specific alkaline phosphatase  
SSEA1                 Stage specific embryonic antigen 1  
ECM                   Extracellular markers 
As                        A-single 
Apr                       A-pair 
Aal                      A-Aligned 
At                          Transient  
GFP                      Green fluorescent protein 
MSCs                   Mesenchymal stem cell  
MEM-a                Minimum Essential Media Alpha 
GPR125              An orphan adhesion-Type G-protein-coupled receptor 
STO                   SIM mouse embryo-derived thioguanine and ouabain- resistant fibroblasts 
TGF-B                  Transforming growth factor–b superfamily  
Camp                  Cyclic adenosine monophosphate  
GFRa1                GDNF family receptor alpha 1 
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SCF                     Stem cell factor  
IGF-1                 Insulin-like growth factor-1  
FSH                     Follicle-stimulating hormone  
SFK                     Src family kinase  
IPSCs                  Induced pluripotent stem cells  
PIPES                 Piperazine-N,N′-bis (2-ethanesulfonic acid) 
DAPI                     4', 6-diamidino-2-phenylindole 
IMH                      Immunohistochemistry  
TAE                     Tris-acetate buffer EDTA 
EGFP                   Enhanced green fluorescent protein  
EBs                      Embryoid Body  
RA                       Retinoic Acid 
NMRI                   Naval Medical Research Institute 
T-Test                Tukey's post-hoc tests  
ES-like                 Embryonic stem cell-like  
MESCs               Mouse embryonic stem cells  
HESCs              Human embryonic stem cells  
C57BL/6       C57 black 6 
H and E  Hematoxylin-Eosin  
MGSCs  Mouse germline stem cells  
Zfp145
–
/
–
mice Zfp145-null mice 
Gli3  GLI-Kruppel family member 3 
SPCs  Spermatogonial progenitor cells  
PI3K  Phosphoinositide 3-kinase  
 Mvh  Mouse homozygotes for VASA homolog gene  
SRY  Sex-determining region Y  
FGFR  FGF receptor  
Ifs  Intermediate filaments  
MCAM  Melanoma cell adhesion molecule  
ICM  Inner cell mass  
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